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According to an estimate from the American Cancer Society in 2018, 1,735,350 people 
were expected to be diagnosed with cancer in the United States, with 609,640 dying from the 
disease. The late diagnosis of cancer has a negative impact on the health care system due to higher 
treatment cost and decreased chances of favorable prognosis. Due to the nature of their profession, 
dentists and their teams are well positioned to identify oral risk markers related to cancer, which 
increases the potential for early diagnosis and chances of survival. For example, tooth agenesis has 
been associated with increased risk for ovarian cancer. A greater awareness of oral conditions that 
are linked to genetic predictors of cancer susceptibility will provide dentists an opportunity to 
improve patient outcomes by suggesting genetic screenings for prevention. The objective of this 
study is to identify craniofacial conditions that might be risk markers for cancers by performing 
association studies and approaches such as a phenome-wide association study (PheWAS) 
including orofacial phenotypes. A PheWAS can determine if clinical traits (phenotypes) or specific 
diagnosis are associated with a given genetic variant. Hence, this study will evaluate if selected 
single nucleotide polymorphisms (SNPs) present in cell regulatory gene pathways are associated 
with orofacial conditions affecting the study population; determine whether there is an increased 
frequency of these conditions among individuals who have been diagnosed with cancer compared 
to healthy controls; and identify the range of head and neck conditions associated with the selected 
SNPs through a PheWAS approach. All samples were obtained through the Dental Registry and 
 v 
DNA Repository (DRDR) at the University of Pittsburgh, School of Dental Medicine. DNA was 
extracted from whole saliva using established protocols and genotyping data from over 3,000 
individuals were generated using TaqMan chemistry. PLINK software was used to perform allele 
frequency tests and a logistic regression using R environment was performed taking covariates 
such as ethnicity and gender into account. We found several genetic associations with the 
phenotypes of interest that were later confirmed with the PheWAS approach. Additionally, novel 
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1.1 Cancer Epidemiology and Potential Markers 
 
Cancer is one of the deadliest diseases and it affects a great number of people worldwide 
(Witsch, Sela, and Yarden 2010). It is a complex disease based on a process that drives the 
transformation of normal cells into their malignant derivatives (Witsch, Sela, and Yarden 2010). 
Approximately 38.4% of people will be diagnosed with some form of cancer in their lifetime 
(Noone 2018). Survival rates vary depending on the type of cancer and the stage at diagnosis. 
Earlier stage diagnosis increases the likelihood of successful treatment and survival rates (Noone 
2018). Nevertheless, because early cancers can be difficult to detect, much focus has been placed 
on the identification of more easily detectable cancer risk markers. A risk marker is a physiologic 
or anatomical characteristic that indicates a genetic tendency of developing the disease in question. 
The BRCA1 and BRCA2 genes are examples of genetic risk markers whose pathogenic variants 
can cause a significant increased risk of breast and ovarian cancer (Santana Dos Santos et al. 2018). 
Additionally, several phenotypic risk markers (i.e., clinical traits), such as anatomical craniofacial 
abnormalities, have also been associated with an increased likelihood of developing cancers 
(Obermair et al. 2019; Machado et al. 2017; Dunkhase et al. 2016; Cordero and Varela-Calvino 
2018; Shi et al. 2018; Corbella et al. 2018; Fekonja, Cretnik, and Takac 2014; Lammi et al. 2004). 
For example, cleft lip/palate has been found to be associated with diffuse gastric cancer (Obermair 
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et al. 2019), breast cancer (Machado et al. 2017), squamous cell carcinoma of the skin and others 
(Dunkhase et al. 2016). Additional studies reported associations between periodontitis and 
colorectal cancer (Cordero and Varela-Calvino 2018), breast cancer (Shi et al. 2018) or any type 
of cancer (Corbella et al. 2018). Lastly, hypodontia (a disorder of tooth development) has been 
correlated with risk for epithelial ovarian cancer (Fekonja, Cretnik, and Takac 2014) and colorectal 
cancer (Lammi et al. 2004). These previous reports point towards the hypothesis that orofacial 
phenotypes are related to cancer risk independent to cancer type. In other words, we can predict 
risk for cancer through the presence of genetic variants or through visual anatomical 
characteristics/ phenotypic traits that have been linked to an increased risk of developing the 
disease.  
The mechanistic understanding of cancer and clinical traits concurrences could be 
explained by genetic and non-genetic factors or the interaction of both factors. For molecular link 
between congenital abnormalities and cancer, the homeobox containing genes and the results of 
fusion events between growth factors and transcription factors have been suggested as culprits of 
unregular cell growth (Bille et al. 2005; Anbazhagan and Raman 1997; Cillo et al. 1999). Another 
possible mechanistic link could be through environmental factors such as carcinogens acting as 
teratogens as well (Bille et al. 2005).  
1.2 The Role of Oral Health Professionals in Cancer Prevention 
Challenges faced by oral health professionals include determining what factors are causing 
oral diseases, what the consequences are of preexisting systemic conditions and understanding 
how a disease can lead to another and determining a definite diagnosis. As a routine visit to the 
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dentist includes examination of the oral cavity and head and neck structures, these professionals 
are well positioned to identify risk markers and phenotypic traits linked to cancer. A better 
understanding of a set of orofacial phenotypes that are markers for cancer risk could enable dentists 
and allied health care professionals to identify high risk patients. Furthermore, greater awareness 
of oral conditions that are linked to genetic predictors of cancer susceptibility will provide dentists 
an opportunity to improve patient outcomes by suggesting screenings for prevention. 
Oral health professionals may also encounter adverse oral health outcomes as a result of 
cancer treatment. Chemotherapy and radiotherapy may affect individual’s immunity and, as 
consequence, change the pattern of their oral health, with individuals showing more problems and 
not responding as well as they might to the traditional dental treatments. Xerostomia, infection, 
abnormal tooth development, taste alteration and mucositis are within the most common oral 
related complications of cancer treatment (Han 2017). Treatments for head and neck carcinomas, 
specifically include a combination of surgery, radiation, and/or chemotherapy. This multimodal 
therapy can result in pain and fibrosis in structures involved with chewing, swallowing and talking, 
causing problems such as nutritional deficiencies, oral health related issues and communication 
impairment (A. Harris et al. 2020). The oral complications listed above can appear as consequences 
of cancer treatment however, some of them and different oral diseases appear before cancer 
diagnosis and could serve as cancer risk markers.  
1.3 Precision Medicine and Phenome-Wide Scan Approach 
Precision medicine is a relatively novel field seen as a hope to better overcome the 
aforementioned challenges. It takes into account individuals’ variability, such as their individual 
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genetics, environment and lifestyle to find individualized measures of disease prevention and 
treatments (Walji, Karimbux, and Spielman 2017). In order to successfully apply precision 
medicine, one needs to understand genotype-phenotype interactions, through the generation of 
phenomic-level data that will allow us to study which genomic variants affect phenotypes 
(Musunuru et al. 2018). Furthermore, this allows for a broader understanding of pleiotropy, which 
is when one gene appears to affect more than one disease or phenotypic trait (Houle, Govindaraju, 
and Omholt 2010). There are two main methodologies used to detect gene-disease associations: 
an approach testing gene variants that can associate to one phenotype [targeted or genome-wide 
association studies (GWAS)] and an approach testing multiple phenotypes that can associate to 
one or more genetic variant (phenome-wide association studies or PheWAS). GWAS has proven 
to be an efficient method of identifying associations between gene variants, including single 
nucleotide polymorphisms (SNPs) and specific diseases. PheWAS is essentially “reverse GWAS” 
whereby one can determine the range of clinical traits (phenotypes) associated with a given 
genotype (Denny et al. 2010). Previous studies have shown the feasibility and success of the 
PheWAS technique to identify multiple associations from well-powered samples (Denny et al. 
2010; Karnes et al. 2017; Pathak et al. 2012; Namjou et al. 2014) and provide novel insights not 
readily attainable by forward-genetic strategies. A unique quality of the PheWAS technique is its 
capacity to evaluate cross-phenotype associations (Hebbring 2019). On the other hand, a similarity 
between PheWAS and different types of association studies is that they are not intended to 
establish disease causation between variants and traits or conditions, but rather to help create 
hypotheses about causal factors for the phenotypes (Musunuru et al. 2018). 
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1.4 Oral Conditions, Systemic Diseases and Gene Pathways Involved 
The most common and most studied oral conditions so far include dental caries and 
periodontal disease, both bacteria-mediated infections (Peres et al. 2020). Efforts such as water 
fluoridation, oral hygiene-based preventive strategies and more aggressive treatment approaches 
are indicated to mitigate and treat dental caries and periodontal disease. Symptoms for these 
distinct conditions can be similar, such as developing discomfort, pain, and inflammation and 
individuals affected by these conditions are also usually more susceptible to additional health 
problems. Dental caries is the most prevalent oral disease and second in the number of people it 
affects worldwide (Edelstein 2006). Dental caries development involves host susceptibility and 
environmental factors such as sugar intake. Bacteria present in the mouth make acids that start 
destroying the tooth enamel and eventually all tooth structures. An extreme outcome of dental 
caries is tooth loss but this condition can also lead to infection and pain (Silk 2014).  
Similarly, periodontal disease is considered a big threat to oral health and the major cause 
of tooth loss (Zhao et al. 2018; Benjamin 2010). It is a chronic inflammatory disease identified by 
the destruction of the tooth-supporting tissues including periodontal-ligament, alveolar bone, and 
cementum. Associations between periodontitis and different systemic conditions are established 
(Chatzopoulos et al. 2018). More specifically diabetes mellitus (Stanko and Izakovicova Holla 
2014), cardiovascular disease (Lockhart et al. 2012), osteoporosis (Ayed et al. 2018), and 
rheumatoid arthritis (Golub et al. 2006) have been associated with periodontitis. 
Overtime, a chronic inflammatory state of both untreated dental caries and periodontal 
disease can lead to inadequate amino acid supply, which lead to reduced protein synthesis and 
degradation (Mercier et al. 2002). Certain pathways that regulate protein synthesis are believed to 
influence multiple conditions, including metabolic disorders, type 2 diabetes and cancers (Rivera 
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Rivera et al. 2016). Some of these specific pathways that haven’t been as much studied regarding 
the genetics of the most prevalent oral conditions include the mammalian target of rapamycin 
(mTOR) and the endoplasmic reticulum stress (ER stress) – the first is a master regulator of protein 
synthesis, composed by Tuberous sclerosis 1 and 2 (TSC1 and TSC2) which are tumor suppressor 
genes. When these genes are activated, mTOR function is repressed, and when TSC1 and TSC2 are 
defective, such as in the tuberous sclerosis complex disease, these genes lose their function, leading 
to hypermineralization of bones. MTOR signaling is comprised of two complexes – mammalian 
target of rapamycin complex 1 (mTORC1) and mammalian target of rapamycin complex 2 
(mTORC2), the first is a center regulator for protein synthesis and the second is a center regulator 
for the serine/threonine kinase (AKT) in the cell. RHEB (Ras homolog enriched in brain) is a 
positive regulator for both mTORC1 and mTORC2, but its function is repressed 
by TSC1 and TSC2 (Brown et al. 1994). In many oncogenes mutated pathways such as the 
PI3K/AKT pathway, mTORC1 acts as a downstream effector, resulting in mTORC1 
hyperactivation in a high number of human cancers (Hua et al. 2019). 
Activation of the mTOR signaling by alcohol use can inhibit mineralization and 
odontogenic differentiation of human dental pulp cells, negatively regulating dental pulp repair 
(Qin et al. 2017). A recent study has shown that when mTOR signaling is inhibited, there is an 
alleviation of the inflammatory response to periodontal pathogens such as Porphyromonas 
gingivalis (Xia et al. 2017), what led us to believe that variation in mTOR signaling genes will play 
a role in periodontal disease outcomes.  
ER stress on the other hand is a phenomenon that occurs when signals emanating from the 
endoplasmic reticulum induce a transcriptional program that enables cells to survive the stress 
generated by an elevated amount of protein synthesized (Schonthal 2012). When affected cells 
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sense there is ER stress, three signal pathways can be activated: ER transmembrane inositol-
requiring enzyme 1 (IRE1) α and β, protein kinase-like ER kinase, and activating transcription 
factor 6 (ATF6) (Reimold et al. 2000). Collectively, these pathways can restore intracellular 
homeostasis. This coordinated response, the unfolded protein response (UPR), facilitates the 
folding, processing, export, and degradation of proteins emanating from the endoplasmic reticulum 
during stressed conditions (Ron and Walter 2007). IRE1 is an endoplasmic reticulum membrane 
domain, which has a dual function of making apoptosis and serving as an endoribonucleous. IRE1 
splices a 26-base pair sequence of Xbp1 (Yoshida et al. 2001). Xbp1 can control many genes that 
are involved in the biogenesis of ER as well as protein folding. In addition, Xbp1 expression was 
also demonstrated to play a role in ameloblasts endoplasmic reticulum volume during enamel 
formation (Tsuchiya et al. 2008). This pathway is essential to maintain intracellular homeostasis 
and in conditions such as in diabetes, research has shown that ER stress modulation is possible 
through mTOR signaling. This approach is effective in suppressing insulin resistance and obesity 
and shows an interplay between ER stress and mTOR signaling (J. Wang, Yang, and Zhang 2016).  
The conditions we are studying here are complex with variable levels of genetic influences 
that modulate both the development of underlying affected structures and active protein synthesis, 
including folding and transport, which are mechanisms not well understood in regards to 
pathogenesis of each oral disease. 
1.5 Hypotheses and Specific Aims 
We hypothesized that:  
 xxi 
1 - Variations in genes belonging to the mTOR and ER stress pathways play a role in oral 
and bone diseases. 
In this section, the first specific aim was to evaluate the presence of these associations by 
comparing the frequency of the selected variants in both affected and unaffected groups of 
individuals for each disease. We generated genotyping data for SNPs present in the mTOR and ER 
stress pathways. Successfully identifying associations provides insights regarding the etiology of 
each studied condition and better ways of diagnosing and preventing them. The second specific 
aim was to determine if associations could be better detected when individuals concomitantly 
affected by more than one disease are analyzed in combination. Our intention was to verify 
potential pleiotropic effects between the studied genes and conditions. 
 
2 – After finding positive results in the first hypothesis we then hypothesized that: A range 
of orofacial phenotypes may be associated with cancer directly, or indirectly through cancer 
associated genes. The results of this section would contribute in determining which patients are at 
higher risk for this condition. To the best of our knowledge, this was the first time a PheWAS was 
applied to oral health outcomes, to identify clinical cancer risk markers. We performed a PheWAS 
to identify patterns of disease in individuals who have been diagnosed with cancer. This approach 
is efficient because it identifies a myriad of associations utilizing a large dataset comprised of 
genetic data in combination with electronic health records information.  
In this section, the first specific aim was to evaluate the frequency of the most common 
orofacial conditions present in individuals who have been diagnosed with cancer and to compare 
those with an unaffected group of individuals using deidentified electronic health record data. In 
this epidemiological analysis we are searching direct associations between cancer and oral 
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phenotypes. Second, we aimed to perform a phenome-wide association study (PheWAS), utilizing 
head and neck clinical information, focusing on individuals who had cancer to identify the range 
of different phenotypes associated with specific SNPs that are also associated with cancers. In this 
indirect analysis we are searching for associations through a genetic component in common 
between conditions. This scientific knowledge changes clinical practice because identification of 
individuals carrying phenotypic or genotypic markers allow dentists to refer them for screenings 
or checkups more frequently. This conduct increases the possibility of diagnosing cancers at early 
stages when the treatment survival rates are higher. 
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 INVESTIGATING WHETHER VARIATION IN MTOR AND ER STRESS GENES 
ARE ASSOCIATED WITH ORAL AND BONE PHENOTYPES 
2.1 FOREWORD 
This chapter is adapted from a previously published manuscript in the Caries Research 
Journal. Bezamat Mariana, Deeley Kathleen, Khaliq Shahryar, et al. 2018. Are mTOR and 
Endoplasmic Reticulum Stress Pathway Genes Associated with Oral and Bone Diseases? Caries 
Research. Copyright © 2018, © 2018 Karger Publishers, Basel, Switzerland. 
2.2 SUBJECTS AND METHODS 
 
Twenty-seven markers in eight genes of the mTOR and ER stress pathways were selected 
in order to be tested in five oral/bone disease phenotypes (dental caries, periapical lesions due to 
deep caries lesions in dentin, periodontitis, osteoporosis, and temporomandibular joint symptoms), 
described in detail below. In this cohort study, a dataset consisting of DNA samples from 3,912 
unrelated subjects who sought treatment at the University of Pittsburgh dental clinics was utilized. 
Individual samples and clinical history were obtained through the Dental Registry and DNA 
Repository (DRDR) of the School of Dental Medicine, University of Pittsburgh. Subjects’ mean 
age was 40.9 ± 19.3 years (ranging from 6 to 92 years-old). This project has the approval of the 
University of Pittsburgh Institutional Review Board (IRB # 0606091). Written informed consent 
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documents were obtained from all subjects. Age appropriate assent documents were used for 
children between 6 and 14 years and signed informed consent documents were obtained from the 
parents. For all comparisons described below, there were no significant differences in the 
distribution of ages and the frequency of self-reported White and Black patients between the two 
comparison groups.  
 Phenotypes and Sample Selection 
Extraction of clinical data was carried out after calibration by an experienced specialist. 
Clinical data included a complete list of oral conditions and treatments present in the database for 
each of the patients seeking care between September 2006 and January 2013. The intra-examiner 
agreement was assessed by a second extraction of clinical data in 10% of the sample after 2 weeks, 
with a kappa of 1.0. Since each phenotype studied is recovered from a registry of clinical 
information derived from the dental clinics of the University of Pittsburgh, calculating inter or 
intra-examiner agreement was not possible. All phenotypes are recorded following the same 
guidelines by students in training under the supervision of experienced dental professionals who 
are calibrated annually. 
 Dental Caries  
We selected 1,481 samples (715 males and 766 females) to evaluate dental caries. The 
presence and severity of dental caries was taken into consideration and we used the decayed, 
missing due to caries and filled teeth (DMFT/dmft) score to assign individuals to one of the 
comparison groups. The population was classified as either having ‘less severe’ (N=553) or ‘more 
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severe’ (N=853) caries experience, based on DMFT/dmft distribution (DMFT/dmft mean and 
standard deviation) and subject’s age. The mean DMFT score was 15.9 with a standard deviation 
of 8.7 and ranged from 0 to 28. The criteria used here for classification of caries experience took 
age into consideration, since it is expected that caries experience will increase in the general 
population with age (Liss et al. 1982). Drinking water in the Pittsburgh area is artificially 
fluoridated. Table 1 describes the criteria defining individuals with higher or lower caries 
experience. This study sample was previously described (Kuchler et al. 2014). 
 
Table 1. Definition of caries experience based on age and DMFT scores. The thresholds were defined based 
on the DMFT distribution in the studied group by age. 
 
Caries Experience Level DMFT/dmft 
Children and teenagers (from 6 to 19 years of age) 
Less Severe Caries Experience 0-3 
More Severe Caries Experience 4 or higher 
Young Adults (from 20 to 39 years of age) 
Less Severe Caries Experience 0-10 
More Severe Caries Experience 11 or higher 
Middle Age (from 40 to 59 years of age) 
Less Severe Caries Experience 0-15 
More Severe Caries Experience 16 or higher 
Elderly (60 years of age and older) 
Less Severe Caries Experience 0-20 
More Severe Caries Experience 21 or higher 
 
Power calculations (Purcell et al. 2007), assuming that our marker alleles were in complete 
linkage disequilibrium with the genetic variant contributing to caries susceptibility, and that the 
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chance of having a distinct (very low or very high) caries susceptibility increased two and a half-
fold when having one copy of the caries susceptibility allele, suggested a 92% power to detect a 
possible association with our sample size. This procedure was for a marker B in linkage 
disequilibrium with our test locus A. Other parameters specified in the calculations were the high-
risk allele frequency for the allele A (set at 0.1); the disease prevalence in the general population 
[set at 0.5, corresponding to the approximate frequency of caries-free individuals or highly affected 
individuals (DMFT=20)], and the genotype risks for the Aa and AA genotypes relative to the 
baseline aa genotype risk. We used most of the same power parameters for all five phenotypes 
(dental caries, periodontitis, periapical pathology, osteoporosis, and temporomandibular joint 
discomfort). 
 Periapical Lesions Due to Deep Carious Lesions in Dentin  
Sixteen hundred radiographic records were screened for subjects with deep carious lesions 
in dentin with or without periapical lesions (≥3mm in diameter). The criteria used to select the 
affected group was the presence of both deep carious lesions and periapical lesions (110 
individuals, 57 males and 53 females with an average age of 57 years and a standard deviation of 
10 years) and for comparison, we selected a group in which they had the presence of deep carious 
lesions but absence of periapical lesions (158 individuals, 65 males and 93 females with an average 
age of 58 years and a standard deviation of 8 years). This cohort of a total of 268 samples has been 
previously reported (Menezes-Silva et al. 2012). We estimated to have 85% power to detect an 
association with the studied sample size. The disease prevalence in the general population was set 
at 0.5, corresponding to the approximate frequency of deep caries lesions and absence of periapical 
lesions in the study sample. 
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 Periodontitis  
Individuals were considered affected if presenting at least three teeth exhibiting sites of 
clinical attachment loss equal or greater to 5 mm in two different quadrants (61 individuals, 22 
males and 39 females). For comparison, we selected individuals showing absence of clinical 
attachment loss and no sites with probing depth greater than 3 mm (325 individuals, 144 males 
and 181 females) totalizing 386 samples selected for genotyping (average age was 50 years with a 
standard deviation of 8 years). This sample has been previously described (Letra et al. 2012). 
Considering a prevalence of periodontitis of 60% (Eke et al. 2012), a power of 80% was estimated 
for this phenotype in our study sample. 
 Osteoporosis  
Twenty-two cases of osteoporosis/osteopenia were identified (20 females and 2 males, 
mean age of 62 years), and 553 unaffected individuals older than 50 years of age (221 men, 332 
women, mean age of 68 years) were selected to serve as comparison. None of the selected cases 
had periodontitis but seven of those had dental caries and were part of the dental caries group 
described above as well. We estimated power as 43% with the sample size we had. The prevalence 
of osteoporosis was set at 0.55, according to the May 2018 Interdisciplinary Symposium on 
Osteoporosis (nof.org). 
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 Temporomandibular Joint Symptoms  
We selected 1,202 women in child bearing age, 521 with a record of, at least, one symptom 
in the temporomandibular joint (clicks, sounds or pain) and 681 without any symptoms that were 
used for comparison. Their mean age was 35.3 years, ranging from 15 to 55 years. Power was 
estimated as 100% to detect a possible association with the studied sample size. The disease 
prevalence in the general population was set at 0.5. 
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 Combined Phenotypes  
We followed the European Federation of Periodontology (EFP) and European 
Organization for Caries Research (ORCA) joint recommendation and analyzed dental caries 
combined with periodontitis within the same individuals (Chapple et al. 2017). In addition, we 
analyzed dental caries combined with periapical pathology and dental caries combined with 
periodontitis and periapical pathology within the same individuals (Figure 1). Osteoporosis and 
temporomandibular joint-symptoms phenotypes were excluded from this analysis since only 22 
cases with confirmed osteoporosis/osteopenia were available and for temporomandibular joint 
symptoms no formal significant associations with the selected genes were found. 
We excluded 24 participants that had missing information about the presence of 
periodontitis or periapical pathology since those conditions were taken into consideration for the 
combined analyses. We found that 794 individuals had periodontitis and recorded caries 
experience (high caries experience, 174 females and 149 males; low caries experience, 229 
females, 242 males), 433 had periapical pathology and recorded caries experience (high caries 
experience, 57 females and 63 males; low caries experience, 158 females, 155 males), and 234 had 
periodontitis, periapical pathology and high caries experience (high caries experience, 31 females 
and 48 males; low caries experience, 90 females, 107 males). Combining the disease phenotypes 





Less severe caries (N = 470) 
Caries 
More severe caries (N= 324) 
Caries 
Less severe caries (N = 313) 
Periapical 
pathology 
More severe caries (N = 120) 
Caries 
Periapical 




More severe caries (cases = 79) 
Figure 1. Combined analysis of more severe and less severe caries experience within individuals affected by periodontal 







 Selection of Genes and Single Nucleotide Polymorphisms 
Since RHEB is a molecule located at the center of the mTOR pathway and can be repressed 
by TSC1 and 2, we chose genes immediately up and downstream of RHEB. RHEB’s role also 
impacts ER stress (Fan et al. 2017). Twenty-seven single nucleotide polymorphisms (SNPs) in 
eight genes were selected (IRE1 -rs196929, rs196950, rs11655020, rs16947425 and 
rs1874087, XBP1 -rs2097461 and rs2239815, RPTOR -rs2289764, rs1012117, rs11651724, 
rs4255830 and rs4396582, TSC1 -rs1050700, TSC2 -rs1051771, rs7187438 and 
rs2073636, RHEB -rs3753151, rs2299967, rs2374261 and rs1109089, RICTOR -rs1239265, 
rs13166875, rs1423688 and rs2043112 and mTOR -rs11580061, rs1010447 and rs11121718). We 
prioritized genes to be studied considering: previous reports of expression in diseased tissues, and 
previous reports of association with bone diseases. In the case of temporomandibular joint 
symptoms, four polymorphisms were tested in IRE1 (rs11655020, rs1874087, rs196950 and 
rs196929) and two in XBP1(rs2097461 and rs2239815). 
SNPs were selected based on published reports and/or their locations in the genes, based 
on their likelihood to have functional consequences (i.e., located in promoter regions, exons or 
near exon/intron boundaries), or if considered tag SNPs as surrogates for the linkage 
disequilibrium blocks surrounding the gene of interest, and their minor allele frequencies. We used 
information from the NCBI dbSNP (http://www.ncbi.nlm.nih.gov/snp) and the HapMap Project 
(http://www.hapmap.org) databases to select the SNPs for this study. 
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 Genotyping 
Genomic DNA was extracted from whole saliva using established protocols. Genotypes 
were generated blindly to clinical diagnosis status. Reactions were carried out using TaqMan 
chemistry (Ranade et al. 2001) in volumes of 3.0 μl in an ABI PRISM Sequence Detection System 
7900 (Applied Biosystems, Foster City, CA, USA). Applied Biosystems supplied assays and 
reagents. The results were analyzed using SDS software version 1.7 (Applied Biosystems). PCR 
reactions were repeated twice when necessary. 
 Data Analyses 
Allele frequencies and Hardy–Weinberg equilibrium were calculated. Association analyses 
were performed comparing genotypes between affected individuals and their respective 
comparison group as implemented in PLINK (Purcell et al. 2007). Assuming that D is the minor 
allele and d is the major allele, the allelic model compares the frequencies of each allele in each 
group (D x d), the genotypic model is an additive two degree of freedom model that compares the 
frequencies of each genotype in the groups (DD x Dd x dd), the dominant model compares the two 
copies of the common allele frequency versus the other combinations (dd x DD + Dd), and the 
recessive model compares the two copies of the rare alleles frequency versus the other 
combinations (DD x Dd + dd). P-values below 0.002 (0.05/27; the denominator is the number of 
genetic markers tested) were considered statistically significant. Additional analysis was 
performed combining patients that have more than one oral disease phenotype (periodontitis, 
periapical pathology, and caries experience), as well as the three oral phenotypes combined. 
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2.3 RESULTS 
We found nominal associations between each of the five phenotypes studied and mTOR or 
ER stress genes. Table 2 shows the summary results for associations between SNPs and the five 
phenotypes. Complete results can be found in the appendix A table 12. Odds Ratios and 95% 
confidence intervals were calculated for significant results (p<0.002) of 1 degree of freedom 
comparisons. Significant associations were found between periapical lesions due to deep carious 
lesions in dentin and RICTOR (p=6.341e-017, OR = 18.82, 95% C.I. 9.25 – 38.29), RHEB 
(p=0.0002, OR = 0.71, 95% C.I. 0.45 – 1.11) and RPTOR (p=0.00022, OR = 3.55, 95% C.I. 1.77 
- 7.10), osteoporosis and mTOR (p=5.971e-008, OR = 8.50, 95% C.I. 3.40 – 21.26), RPTOR 
(p=0.001, OR = 0.73, 95% C.I. 0.30 – 1.74), RICTOR (p=0.0004, OR = 4.47, 95% C.I. 1.36 – 
14.65), IRE1 (p=0.00021, OR = 2.71, 95% C.I. 1.37 – 5.35), XBP1 (p=0.00095, OR = 2.76, 95% 
C.I. 1.34 – 5.65) and TSC2 (p=1.0e-5, OR = 0.04, 95% C.I. 0.007 – 0.30), and dental caries 
and RPTOR (p=0.00079, OR = 1.50, 95% C.I. 1.18 – 1.91) (Table 2).  
In the combined analysis 27% of the patients had concomitant periapical lesions and more 
severe caries experience, 40% had concomitant periodontal disease and more severe caries 
experience and 33% had all three diseases concomitantly. When combining patients that had 
concomitant dental caries and periapical lesions, both tested markers in RHEB showed 
associations, and for the group of concomitant dental caries, periodontitis, and periapical 





Table 2. Summary of results highlighting nominal (between 0.05 and 0.002) and statistically significant (equal 
or lower than 0.002, marked in bold) p-values for association analyses between periapical lesions, periodontal 
disease, osteoporosis, dental caries experience, and temporomandibular joint symptoms and the evaluated 
markers. Assuming that D is the minor allele and d is the major allele, the allelic model compares the 
frequencies of each allele in each group (D x d), the genotypic model is an additive two degree of freedom model 
that compares the frequencies of each genotype in the groups (DD x Dd x dd), the dominant model compares 
the two copies of the common allele versus the other combinations (dd x DD + Dd), and the recessive model 




Gene  SNP          Allele1/2   TEST     Affected      Unaffected         X2      DF      P-value 
IRE1  rs11655020    A    G     GENO     40/256/240     73/441/303        8.037    2      0.01798 
IRE1  rs11655020    A    G  ALLELIC        336/736       587/1047        6.044    1      0.01396 
IRE1  rs11655020    A    G      DOM        296/240        514/303        7.965    1      0.00477 
RPTOR rs11651724    A    G     GENO     21/112/170     18/160/353        11.24    2     0.003619 
RPTOR rs11651724    A    G  ALLELIC        154/452        196/866        11.26    1     0.000791 
RPTOR rs11651724    A    G      DOM        133/170        178/353        8.876    1     0.002889 
RPTOR rs11651724    A    G      REC         21/282         18/513        5.426    1      0.01984 
Periodontal disease 
TSC1   rs1050700    C    T  ALLELIC          39/47        165/317        3.918    1      0.04776 
TSC1   rs1050700    C    T      DOM          29/14        123/118        3.947    1      0.04694 
IRE1    rs196929    T    C     GENO       14/15/12       37/86/93        6.723    2      0.03468 
IRE1    rs196929    T    C  ALLELIC          43/39        160/272        6.842    1     0.008906 
IRE1    rs196929    T    C      REC          14/27         37/179        6.273    1      0.01226 
IRE1    rs196950    T    C  ALLELIC          57/55        216/316        4.013    1      0.04516 
IRE1   rs1874087    C    T  ALLELIC          54/34        145/169        6.341    1       0.0118 
IRE1   rs1874087    C    T      DOM           36/8         101/56        4.843    1      0.02777 
RPTOR  rs2289764    C    T  ALLELIC          39/45        152/308        5.586    1      0.01811 
Periapical Lesions 
RICTOR rs1239265    A    T  ALLELIC         62/126         10/254        69.87    1   6.341e-017 
RICTOR rs1239265    A    T     GENO       10/42/42        2/6/124        68.38    2   5.461e-016      
RICTOR rs1239265    A    T      DOM          52/42          8/124        68.31    1   4.231e-016      
IRE1    rs196950    T    C  ALLELIC          63/89         69/155        4.503    1      0.03383 
XBP1   rs2097461    C    T     GENO        8/40/27       18/38/52        6.055    2      0.04844 
RHEB   rs3753151    C    T     GENO        2/39/18       33/49/45        17.17    2      0.00019 
RHEB   rs3753151    C    T      REC           2/57          33/94       13.463    1       0.0002 
RPTOR  rs2289764    C    T  ALLELIC          79/93         64/150         10.5    1      0.00119 
RPTOR  rs2289764    C    T      REC          33/57          15/92        13.60    1     0.000225 
Osteoporosis 
RHEB   rs1109089    T    C      REC           0/19         98/398        4.636    1       0.0313 
MTOR  rs11580061    G    A  ALLELIC           7/29         25/881        29.37    1   5.971e-008 
MTOR  rs11580061    G    A     GENO         3/1/14       0/25/428       55.482    2     0.000047 
MTOR  rs11580061    G    A      DOM           4/14         25/428         8.36    1      0.00384 
MTOR  rs11580061    G    A      REC           3/15          0/453        75.98    1     0.000032 
RICTOR rs1239265    A    T  ALLELIC           4/24         14/376        7.253    1     0.007079 
RICTOR rs1239265    A    T     GENO         2/0/12       2/10/183       12.811    2     0.001653 
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RICTOR rs1239265    A    T      REC           2/12          2/193        12.23    1      0.00047 
TSC2   rs1051771    C    G  ALLELIC           6/28         66/892        5.645    1       0.0175 
TSC2   rs1051771    C    G     GENO         2/2/13       3/60/416       20.417    2       4.0e-5 
TSC2   rs1051771    C    G      REC           2/15          3/476        20.41    1       1.0e-5 
RPTOR rs11651724    A    G     GENO         3/1/11     12/103/234        12.284   2      0.00215 
RPTOR rs11651724    A    G      REC           3/12         12/337        9.984    1      0.00158 
RPTOR  rs1012117    A    G     GENO          5/5/5     53/213/215        7.015    2      0.02998 
RPTOR  rs1012117    A    G      REC           5/10         53/428        7.014    1     0.008085 
XBP1   rs2097461    C    T  ALLELIC          19/13        353/667        8.327    1     0.003907 
XBP1   rs2097461    C    T     GENO          7/5/4     71/211/228        11.06    2      0.00396 
XBP1   rs2097461    C    T      REC            7/9         71/439        10.93    1      0.00095 
XBP1   rs2239815    C    T  ALLELIC          20/16        383/627        4.564    1      0.03264 
XBP1   rs2239815    C    T      REC           7/11         90/415        5.106    1      0.02384 
IRE1  rs16947425    A    C     GENO         5/4/10     12/145/320       31.303    2       5.0e-5 
IRE1  rs16947425    A    C  ALLELIC          14/24        169/785        8.887    1     0.002872 
IRE1  rs16947425    A    C      REC           5/14         12/465        31.27    1      0.00021 
IRE1  rs11655020    A    G      REC           5/12         53/452        5.959    1      0.01464 
Temporomandibular joint symptoms 
IRE1   rs1665020    A    G  ALLELIC        185/693        273/823         4.03    1      0.04469 
IRE1   rs1665020    A    G      DOM        145/294        220/328        5.297    1      0.02137 
 
 
Table 3. Summary of all nominal (p-values between 0.05 and 0.002) and significant results from the combined 
analysis of patients with caries, periodontitis and periapical lesions (bold indicates statistically significant p-
values under the threshold 0.002). Assuming that D is the minor allele and d is the major allele, the allelic 
model compares the frequencies of each allele in each group (D x d), the genotypic model is an additive two 
degree of freedom model that compares the frequencies of each genotype in the groups (DD x Dd x dd), the 
dominant model compares the two copies of the common alleles frequency versus the other combinations (dd 
x DD + Dd), and the recessive model compares the two copies of the rare alleles frequency versus the other 
combinations (DD x Dd + dd). 
 





RPTOR rs1012117 0.05 Recessive 
RHEB rs1109089 0.02 Dominant 
RICTOR rs1423688 0.03 Recessive 
RPTOR rs2374261 0.02 Genotype 
RHEB rs2374261 0.004 Dominant 
RPTOR rs4396582 0.03 Genotype 
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RHEB rs1109089 0.002 Genotype 
RHEB rs1109089 0.0006 Allelic 
RHEB rs1109089 0.0007 Dominant 
RHEB rs2374261 0.003 Genotype 
RHEB rs2374261 0.0007 Allelic 
RHEB rs2374261 0.001 Dominant 
IRE1 rs16947425 0.04 Recessive 
IRE1 rs196950 0.04 Allelic 
XBP1 rs2239815 0.04 Dominant 
TSC1 rs1050700 0.04 Genotype 
TSC1 rs1050700 0.04 Allelic 






RHEB rs1109089 0.005 Genotype 
RHEB rs1109089 0.003 Allelic 
RHEB rs1109089 0.001 Dominant 
RHEB rs2374261 0.0009 Genotype 
RHEB rs2374261 0.0003 Allelic 
RHEB rs2374261 0.0002 Dominant 
IRE1 rs16947425 0.04 Allelic 
RPTOR rs4396582 0.001 Allelic 
RPTOR rs11651724 0.007 Genotype 
RPTOR rs11651724 0.001 Allelic 




Although caries is most times a preventable disease, it is still very common all over the 
world. Many factors can play a role in the dental caries phenotype, such as the high level of 
consumption of sugar and carbs, the oral microbiota, lack of exposure to fluorides from drinking 
water and/or dentifrices, and poor oral hygiene. Even though fluoridated water is common in most 
countries, this practice might soon be challenged. Evidence has shown decreased cognitive 
performance by prenatal exposure to fluoride (Green et al. 2019).  
Not only the aforementioned factors contribute for dental caries development, but evidence 
also suggest that individual genetic variation plays a role in the disease process as well (Vieira et 
al. 2012). Furthermore, genetic factors related to the host, that are represented by genes involved 
with enamel formation, saliva composition, dietary preferences, and immune response (Shuler 
2001), can be involved in caries susceptibility. Genes in the mTOR pathway are involved in dental 
mineralization (Kim et al. 2011) and hence could contribute to caries susceptibility. In addition, 
fluoride induces ER stress and interferes with enamel proteinase secretion (Wei et al. 2013), which 
may result in alterations of enamel structure that can modify individual susceptibility to dental 
caries. 
MTORC1 is a ternary complex containing mTOR, RPTOR (Regulatory Associated Protein 
of mTOR) and G-BetaL. MTORC1 regulates VEGF (Vascular Endothelial Growth Factor) by 
inducing HIF1α (Brugarolas et al. 2003). The association between genetic variation in RPTOR and 
cases with more severe caries experience may be related to a mechanism that involves individuals 
more susceptible to carious lesion progression in enamel and dentine. 
When the dental caries phenotype is defined as having caries or not having caries, DMFT 
score 0 versus DMFT score 1 or higher, it may not be feasible to detect genes that may contribute 
 xxxviii 
to the severity of the disease. This is probably the general limitation of the work done by us and 
others, both including candidate gene approaches (Tannure, Kuchler, Falagan-Lotsch, et al. 2012; 
Tannure, Kuchler, Lips, et al. 2012) and genome wide scan analyses (Shaffer et al. 2011; X. Wang 
et al. 2012). If anybody with any recorded DMFT score is assigned to the disease group, this group 
will have individuals with very little caries experience (DMFT scores 1 or 2) along with individuals 
with much higher DMFT scores. We believe a DMFT score of 1 is not under the same influences 
of a DMFT score of 10, having one decayed tooth is much less of a severe disease than having 10 
teeth affected for example. Although it may be surprising for many, Pittsburgh is the largest city 
of the Appalachian region, which is one of the poorest areas of the US, and consequently a region 
with very poor health indicators, including oral health indicators (Anjomshoaa, Cooper, and Vieira 
2009). The phenotyping scheme used in our study takes into account ages and distribution of caries 
experience in the study participants. Individuals with very severe caries experience (DMFT higher 
than 10 by 20 years of age) demonstrated an association with a genetic variant in RPTOR. We have 
previously tested modifying the cut-off thresholds of those definitions and shown that there are no 
dramatic differences when the threshold is moved slightly (DMFT cut-off 9 in comparison to 10 
or 11 (Deeley et al. 2008; Shimizu et al. 2013), but the limitation continues to be that we lose 
statistical power when trying to make more distinct groups eliminating intermediate values 
(comparing caries free with individuals with DMFT 10 or higher). 
This is the first study that has provided evidence for association between a gene in 
the mTOR pathway and caries. RPTOR, particularly associated with dental caries in this study, 
regulates cell growth in response to nutrient and insulin levels (Foster et al. 2010). This information 
may turn out to be relevant for further cancer studies. We found that periodontal disease and 
osteoporosis were associated with SNPs in IRE1 with allele A of rs16947425 increasing the risk 
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of osteoporosis almost 3-fold (p=0.00021, OR = 2.71, 95% C.I. 1.37 – 5.35). This result is 
remarkable, IRE1 is involved in the development of secretory cells and organs (Reimold et al. 
2000) as well as osteoclastogenesis (Tohmonda et al. 2015), suggesting that IRE1 deficiency may 
induce osteopenia/osteoporosis with a slow bone turnover. However, these results should be taken 
cautiously particularly for osteoporosis, due to our study sample size of only twenty-two cases, it 
is difficult to estimate true odds ratios. 
Recent evidence indicates that the inhibitory effects of TSC1/TSC2 is mediated 
through TSC2 inactivation of RHEB and it has been postulated that TSC1/TSC2 complex 
inhibits mTOR signaling, that pathway is a central regulator of proliferation and cellular growth. 
Without this functional signaling, cells at the inflammatory sites cannot regenerate, and 
consequently there will be periodontal tissue destruction or higher predisposition for pulp 
inflammation even under slow progressing deep caries lesions in dentin. This process will be 
aggravated by swollen gums and accumulation of plaque. 
In this present study, we have done a combined analysis of three phenotypes with the 
intention of finding a pleiotropic effect of the genotyped variants in the studied phenotypes. 
Previous studies looking at genetic variants were inconclusive in evidencing an association 
between caries and periodontitis; none of the gene variants that showed association with 
periodontitis had been associated with caries before (Nibali et al. 2017). In our study, both 
rs2374261 and rs1109089 markers in RHEB showed associations under the dominant model with 
individuals that had concomitant caries and periodontitis. This approach might be efficient in 
finding pleiotropic genes associated with oral phenotypes and help identify individuals with poor 
oral health outcomes and prognosis. We believe that sophisticating phenotype descriptions (Vieira 
2018) and looking for patterns of disease affection (Koruyucu et al. 2018; Weber et al. 2018) based 
 xl 
on common underlying mechanisms (i.e. inflammation) are more promising approaches for 
identifying genes contributing to poor oral health outcomes than genome-wide association studies 
that use crude phenotypical descriptions such as “caries-free” versus ‘caries-affected”.  
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 PERFORMING AN ORAL PHENOME-WIDE SCAN IN CANCER DIAGNOSED 
INDIVIDUALS 
3.1 FOREWORD 
This chapter is adapted from a previously published manuscript in the Scientific Reports 
Journal. Mariana Bezamat et al. 2020. Phenome-Wide Scan Finds Potential Orofacial Risk 
Markers for Cancer. Scientific Reports. Copyright © 2020, Mariana Bezamat et al. Springer 
Nature. 
3.2  SUBJECTS AND METHODS 
Data from the Dental Registry and DNA Repository project available at the University of 
Pittsburgh were again used in this aim. All methods were performed in accordance with the 
guidelines and regulations. When data were collected, approximately 6,100 unrelated individuals 
who provided written informed consent were available (Vieira, Hilands, and Braun 2015; Vieira 
et al. 2017). Biospecimens were linked to patients’ complete electronic health record (EHR) data 
(available on REDCap system), thus permitting analysis of associations between genetic variation 
obtained from DNA extracted from the specimens and dental and medical conditions. All data 
were deidentified, and biospecimens were linked to EHRs using a unique study number rather than 
personal identifying information. Complete medical and dental records, radiographs, oral 
photographs, and information about possible risk factors for cancer and other chronic conditions 
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were available, under specific codes created for the project. From the study database, a total of 350 
individuals who have been diagnosed with cancer were first selected for the study. Then, a 
comparison group comprised of individuals who have never received a cancer diagnosis and were 
matched to the 350 patients in the experimental group by age, ethnicity, and sex reaching a 1:4 
ratio was selected. Table 4 shows the distribution of the study sample and Figure 2 describes the 
overall study design. 
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Table 4. Study sample characteristics. 
 
 Individuals with a Diagnosis of 
Cancer 
(n=350) 
Matched Individuals    without 
a Diagnosis of Cancer 
 (n=1,321) 
Age in years (mean, range) 60.9 (13-91) 60.6 (13-97) 
Sex (n, %) 
Female 187 (53.43%) 719 (54.43%) 
Male 163 (46.57%) 602 (45.57%) 
Self-reported  
Ethnicity (n, %) 
White 265 (75.71%) 1,042 (78.88%) 
Black 75 (21.43%) 266 (20.14%) 
Asian 2 (0.57%) 7 (0.53%) 
Hispanic 3 (0.86%) 6 (0.45%) 




Figure 2. Overall study design. 
 
The types of cancer in the study population are described by sex in Table 5. Phenotypes 
examined in this study included dental caries, diseases of the dental pulp and periapical tissues, 
dental abscess, diseases of the jaw, missing teeth or edentulism, acute periodontitis, chronic 
periodontitis, disorders of tooth development or eruption, tooth fracture, sleep related movement 
disorders (e.g., bruxism), diseases of salivary glands, malocclusion, stomatitis, mucositis, 
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erythema, lingual varicose veins, diseases of the tongue, temporomandibular joint disorder, 
hemangioma, lymphadenitis, candidiasis, thyroid disorders, and lacrimal gland disorders. 
 
Table 5. Types of cancers in the study sample by sex. 
 
Males Females 
Cancer type # Cases Cancer type # Cases 
Prostate 38 Breast 56 
Skin 35 Skin 29 
Lymphoma 12 Cervix 19 
Kidney 10 Colon/rectal 17 
Rectal 9 Thyroid 12 
Liver 6 Ovarian 7 
Testicular 6 Leukemia 6 
Throat 5 Lung 6 
Lung 4 Uterine 5 
Bladder 4 Oral 2 
Thyroid 3 Myeloma 2 
Oral 3 Head 2 
Leukemia 3 Bladder 2 
Parotid gland 2 Endometrial 2 
Esophagus 2 Throat 1 
Brain 2 Liver 1 
Adenocarcinoma 2 Adenocarcinoma 1 




 Phenotype-to-phenotype analysis 
Individuals diagnosed with cancer were matched with individuals without cancer according 
to their age, ethnicity and sex, since these variables associate with the onset or frequency of many 
outcomes we selected to study. Then, a chi-square test (alpha = 0.05) was performed to ascertain 
if particular dental outcomes preferentially associated with each other. The frequency of the most 
common head and neck conditions in the group of individuals who received a diagnosis of cancer 
was compared with the group of individuals who were not diagnosed with cancer. We tested 
phenotypes such as the presence of diseases of pulp and periapical tissues, periodontitis (acute or 
chronic), tooth loss/edentulism, dental caries and anomalies of jaw size/symmetry.  
Since we had medical information available to us, we further tested if additional 
comorbidities associated with cancer in our study population as well. The self-reported 
comorbidities tested were epilepsy, stroke, asthma, tuberculosis, anemia, hepatitis, liver disease, 
irregular heartbeat, rheumatic fever, heart murmur, heart surgery, diabetes, HIV and kidney 
disease. The analysis included two-by-two tables and chi-square tests with an alpha set to 0.05. 
 Genomic polymorphisms 
We have tested SNPs based on the data obtained in section 1, where we tested 27 markers 
in eight genes of two pathways involved with protein synthesis and cell homeostasis, and five oral 
phenotypes (Bezamat et al. 2019). Results showed that the SNPs rs2374261 (RHEB), rs1109089 
(RHEB), rs4396582 (RPTOR) and rs196929 (IRE1)  associated with three oral phenotypes (dental 
caries, periodontitis, and periapical lesions). Those SNPs are present in pathways involved in cell 
proliferation, differentiation, protein synthesis and inflammation, and may contribute to cancer 
risk as well. We also tested variation marking AXIN2 (rs2240308 and rs11867417), based on its 
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association with cancer in different populations as well as craniofacial phenotypes such as cleft lip 
and palate and tooth agenesis, reported in previous studies (Lammi et al. 2004; Callahan et al. 
2009; Ma et al. 2014; D. Liu et al. 2014; Z. Wu et al. 2015; X. Liu et al. 2016; Y. Han et al. 2014; 
Letra et al. 2009; S.S. Wang et al. 2006). Table 6 lists the genes, the selected SNPs and their minor 
allele frequencies (MAF). 
 
Table 6. Selected SNPs and their minor allele frequencies (MAF). 
 
Gene SNP MAF 








rs11867417         
A=0.3377 
C=0.4675 
RPTOR rs4396582 G=0.4113 
 
 DNA extraction 
Genomic DNA was extracted from salivary samples of the 1,671 individuals using 
established protocols (Aidar and Line 2007). In order to run the polymerase chain reaction (PCR) 
using the selected SNPs, DNA samples were diluted in Tris- EDTA (TE) buffer to a concentration 
of 2 ng/μl. Then, a volume of 1.0 μl was transferred to PCR plates and 2.0 μl of reaction mix 
containing master mix, water and the SNP of interest was added to each well of the 384 well plate. 
Reactions were carried out using TaqMan chemistry in volumes of 3.0 μl in an ABI PRISM 
Sequence Detection System 7900, software version 1.7 (Applied Biosystems, Foster City, CA, 
USA). Genotypes were generated blindly to clinical diagnosis status. 
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 Genotypic analysis  
Association analyses were performed comparing genotypes and allele frequencies between 
individuals diagnosed with cancer and the unaffected group for each SNP as implemented in 
PLINK (Purcell et al. 2007). Different models are available, the allelic model compared the 
frequencies of each allele in each group (D x d); assuming that D is the minor allele and d is the 
major allele. The genotypic model is an additive two degree of freedom model and compared the 
frequencies of each genotype in the groups (DD x Dd x dd), the dominant model compared the 
two copies of the common alleles frequency versus the other combinations (dd x DD + Dd), and 
the recessive model compared the two copies of the rare alleles frequency versus the other 
combinations (DD x Dd + dd). P-values below 0.008 (0.05/6; the denominator is the number of 
genetic markers tested) were considered statistically significant. 
 
 Code conversion 
As the Dental Registry and DNA Repository project uses internal specific codes that better 
describe dental conditions instead of the more general International Classification of Diseases - 
Ninth Revision (ICD-9), and the PheWAS package in R studio only reads ICD-9 codes or 
“Phecodes”, we included as part of our strategic approach the conversion of our internal codes into 
“Phecodes” to be able to run the PheWAS analysis. Treatments and phenotypes were recoded and 
identified by “Phecodes” and each tooth might have more than one code according to the number 
of different phenotypes in the tooth. The information of treatments previously provided is 
important to help us determine whether a tooth had previous dental caries, successive restorations’ 
failures or unsuccessful treatments leading to extractions for example. The way the program is 
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written, the use of universal codes or “Phecodes” is required for the analytic software to perform 
the analysis of these data. The raw data were gathered from the Dental Registry and DNA 
Repository project through REDCap (Research Electronic Data Capture) hosted at the University 
of Pittsburgh (P.A. Harris et al. 2009). Data were exported in the form of an Excel file, which was 
converted to a Comma Separated Variable file (.CSV). The.CSV file was then read and processed 
by a script that converted all relevant codes from project’s internal form to their Phecode form. A 
program was written in JavaScript to read the .CSV file. A list of valid conversions was manually 
created by us (Appendix Table 13) according to the codes we have available in our project and a 
phecode catalog map that can be found at www.phewascatalog.org - the codes can be identified 
by either typing the correspondent ICD9 code or the phenotype of interest. The list also in the 
.CSV form, was entered into the script, and the program replaced all occurrences of relevant raw 
codes to their Phecode form and a “true or false” file was manually created for each of the 
phenotypes in a particular individual. This final file was then uploaded into R to be used in the 
PheWAS analysis. 
 PheWAS statistical methods and power calculation 
The R software has a PheWAS package that generates perfect matches between affected 
individuals and their comparators for each individual set of phenotypes. Each phenotype includes 
an optional set of exclusion phenotypes for similar diagnoses to more accurately identify true 
controls. This step prevents patients with similar diseases from being marked as a control during 
the statistical analysis (Carroll, Bastarache, and Denny 2014). The current PheWAS map and 
PheWAS script written in R is available at http://phewascatalog.org (Carroll, Bastarache, and 
Denny 2014). The standard PheWAS statistical test is a logistic regression that calculates odds 
ratios, p-values, and includes Bonferroni correction to account for multiple testing. We used the 
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additive genomic model, assuming that each allele contributes a fixed amount of risk that is 
additive. We incorporated sex and ethnicity as covariates in the logistic regression analysis in order 
to adjust for potential confounding effects. 
According to a simulation study that investigated power estimates in PheWAS, a sample 
size of 200 cases or more achieves 80% statistical power to identify associations for common 
variants. In addition, a sample size of 1,000 or more individuals performed best in the simulations 
(Verma et al. 2018). Our total sample consists of 1,671 individuals, 350 diagnosed with cancer and 
1,321 non-affected by cancer, which gives an approximate 1:4 case-control ratio. Considering 
sample size, case-control ratio, and minor allele frequencies of our SNPs (Table 6), the analysis of 
the cohort defined by having cancer will have a power of 100% to detect possible associations 
with α at 0.00025. 
3.3 RESULTS 
We performed a phenotype-to-phenotype analysis, in which we compared the frequency of 
the most common orofacial conditions between cancer diagnosed individuals and a group of 
patients that were not diagnosed with cancer. As expected, the frequency of some oral diseases is 
high in the individuals participating in the Dental Registry and DNA Repository project. For 
example, among the 350 patients who reported having cancer, 84 have been diagnosed with 
periodontitis and 134 have been diagnosed with diseases of pulp and periapical tissues, versus 304 
and 490 individuals out of 1,321 in the group without cancer for the same respective treatments. 
The most frequent condition was tooth loss/edentulism with 327 individuals being affected in the 
cancer diagnosed group versus 1147 in the group without cancer. We used these frequencies to 
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calculate power, considering the incidence of tooth loss/edentulism in the affected group as 93%, 
and in the unaffected as 87%. Our total sample of 1,671 individuals gives 91% power to detect 
associations with an alpha of 0.05. When less frequent phenotypes or more similar incidence 
percentages within comparison groups are considered, the power decreases substantially. All 
additional power calculations for each individual condition are represented in Table 7. 
 
Table 7. Oral conditions present in patients diagnosed with and without cancer, chi-square results (P-value 
below the significance threshold of 0.05 is marked in bold) and statistical power.  
 




P-value Odds Ratio Statistical 
Power 
Diseases of pulp 
and periapical 
tissues  
134 490 0.68 1.05 5.4% 
Periodontitis (acute 
or chronic) 
84 304 0.69 1.05 6% 
Tooth 
loss/edentulism 
327 1,147 0.0006 2.15 91% 
Dental caries  237 843 0.17 1.18 28.2% 
Anomalies of jaw 
size/symmetry 
5 22 0.75 0.85 3.9% 
 
The results showed that having tooth loss makes one more likely to have been diagnosed 
with cancer [327 out of 350 have tooth loss in the affected group and 1,147 out of 1,321 in the 
unaffected group (p = 0.0006, OR = 2.15, 95% C.I. 1.37–3.38)]. All the remaining orofacial 
phenotypes tested did not show any statistical difference between the two compared 
groups (Table 7).  
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Our additional chi-square analysis between cancer and the presence of comorbidities 
identified several associations such as with hepatitis (p = 0.0007), asthma (p = 0.01), heart murmur 
(p = 0.001), diabetes (p = 0.01), kidney disease (p = 0.02) and anemia (p = 0.01) with the cancer 
group. In the genotypic analysis an association between the group of individuals affected with 
different cancers and IRE1 rs196929 was identified in the genotypic (2df) model (Table 8). The 
heterozygous genotype (TC) was more frequent than the homozygous genotypes in the individuals 
diagnosed with cancer whereas the homozygous for allele 2 genotype (CC) was more frequent in 
the unaffected matched controls. 
 
Table 8. Results from the genotypic analysis of patients diagnosed with cancer (bold indicates statistically 
significant p-values under the threshold 0.008). Assuming that D is the minor allele and d is the major allele, 
the allelic model compares the frequencies of each allele in each group (D x d), the genotypic (GENO) model is 
an additive two degree of freedom model that compares the frequencies of each genotype in the groups (DD x 
Dd x dd), the dominant (DOM) model compares the two copies of the common alleles frequency versus the 
other combinations (dd x DD + Dd), and the recessive (REC) model compares the two copies of the rare alleles 
frequency versus the other combinations (DD x Dd + dd). Chromossome (CHR), Allele 1 and 2 (A1, A2), Chi-
square value (X2). 
 




7 rs1109089 T C GENO 66/153/104 278/524/421 2.172 2 0.3375 
7 rs1109089 T C ALLELIC 285/361 1080/1366 0.0002697 1 0.9869 
7 rs1109089 T C DOM 219/104 802/421 0.5643 1 0.4526 
7 rs1109089 T C REC 66/257 278/945 0.7797 1 0.3772 
7 rs2374261 T C GENO 62/146/102 259/500/404 1.759 2 0.415 
7 rs2374261 T C ALLELIC 270/350 1018/1308 0.009432 1 0.9226 
7 rs2374261 T C DOM 208/102 759/404 0.3653 1 0.5456 
7 rs2374261 T C REC 62/248 259/904 0.74 1 0.3897 
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17 rs196929 T C GENO 32/153/123 152/472/569 10.31 2 0.0058 
17 rs196929 T C ALLELIC 217/399 776/1610 1.617 1 0.2035 
17 rs196929 T C DOM 185/123 624/569 5.932 1 0.01487 
17 rs196929 T C REC 32/276 152/1041 1.258 1 0.262 
17 rs4396582 G A GENO 76/156/93 272/576/335 0.04994 2 0.9753 
17 rs4396582 G A ALLELIC 308/342 1120/1246 0.000458 1 0.9829 
17 rs4396582 G A DOM 232/93 848/335 0.0111 1 0.9161 
17 rs4396582 G A REC 76/249 272/911 0.0221 1 0.8818 
17 rs11867417 T C GENO 48/111/85     160/388/335        0.8472     2 0.6547 
17 rs11867417 T C ALLELIC 207/281        708/1058        0.8588     1 0.3541 
17 rs11867417 T C DOM 159/85         548/335        0.7872     1 0.3749 
17 rs11867417 T C REC 48/196         160/723         0.306     1 0.5801 
17 rs2240308 A G GENO 46/134/106     230/455/403          4.22     2 0.1212 
17 rs2240308 A G ALLELIC 226/346        915/1261         1.203     1 0.2728 
17 rs2240308 A G DOM 180/106         685/403    4.914e-
005     
1 0.9944 
17 rs2240308 A G REC 46/240         30/858         3.606     1 0.05756 
 
The PheWAS analysis (Table 9) revealed several suggestive associations between 
craniofacial phenotypes and the SNPs tested. However, there were no significant associations after 
Bonferroni correction. A trend for association was found between AXIN2 rs11867417 minor allele 
and the presence of glossitis (p = 7.80E-04, OR = 2.48, 95% C.I. 1.49–4.36). Figure 3 illustrates 
the most substantial results in the total sample. We set a threshold value of p = 0.002 (horizontal 
red line) in all Manhattan plots in order to facilitate visualization of trends for association. The 
horizontal blue line represents the p = 0.05 threshold, phenotypes found below the blue line are not 
annotated in the plots to avoid noise. The triangle tip direction represents the odds ratio direction 
of each association. In order to identify whether these associations were preferentially linked to 
the individuals with a cancer condition in our population, we ran PheWAS in both cancer-
affected (Figure 4 and Table 10) and unaffected samples separately (Table 11). Table 10 shows 
the results obtained in the cancer-affected sample and table 11 shows the results obtained after 
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analysis of the cancer-unaffected sample. When analyzing the cancer affected group separately, 
tooth loss/edentulism and leukoplakia of oral mucosa are within the phenotypes that showed trends 
for association with a number of different SNPs. Interestingly, when the comparison group was 
analyzed, no significant associations with these phenotypes were identified, leading us to suggest 
that they are possibly unique to the cancer affected sample. 
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Table 9. PheWAS results in the total sample. Logistic regression using the additive genomic model was 

















525 Tooth fracture rs2374261_T 1.187 1.849 1.480 5.08E-04 181 (12%) 1289 (88%) 0.43 
529.1 Glossitis rs11867417_C 1.498 4.368 2.486 7.80E-04 39 (3%) 1088 (97%) 0.59 









rs2374261_T 1.045 1.409 1.213 1.08E-02 555 (38%) 915 (62%) 0.43 


















rs4396582_G 1.015 1.949 1.403 4.07E-02 78 (5%) 1427 (95%) 0.47 
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Table 10. PheWAS results in the patients that had cancer. Logistic regression using the additive genomic model 
was performed and the table shows the nominal results (p values between 0.00025 and 0.05). Significant results 




















rs1109089_T 0.384 0.841 0.572 0.0052 80 (25%) 240 (75%) 0.44 
rs2374261_T 0.383 0.858 0.578 0.0076 75 (24%) 239 (76%) 0.43 
523.1 Gingivitis 
rs11867417_C 0.413 0.927 0.623 0.0213 70 (29%) 169 (71%) 0.57 








rs2240308_A 1.134 4.979 2.269 0.0281 263 (92%) 22 (8%) 0.41 





rs2240308_A 0.448 0.945 0.655 0.0257 86 (30%) 199 (70%) 0.41 
rs2374261_T 1.029 2.096 1.464 0.0348 95 (30%) 219 (70%) 0.43 
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Table 11. PheWAS results in the patients that did not have cancer. Logistic regression using the additive 
genomic model was performed and the table shows the nominal results (p values between 0.00025 and 0.05). 
Significant results were not identified. 
 















rs2374261_T 1.140 1.884 1.464 2.89E-03 137 (12%) 1019 (88%) 0.44 
rs1109089_T 1.130 1.850 1.444 3.37E-03 141 (12%) 1081 (88%) 0.44 




rs2374261_T 1.067 1.675 1.336 1.14E-02 178 (15%) 978 (85%) 0.44 
rs1109089_T 1.020 1.572 1.266 3.20E-02 193 (16%) 1029 (84%) 0.44 
529.1 Glossitis rs11867417_C 1.211 3.914 2.113 1.16E-02 31 (3%) 857 (97%) 0.60 
523.1 Gingivitis rs2240308_A 0.659 0.949 0.792 1.21E-02 320 (29%) 769 (71%) 0.42 
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Figure 3. Plot representing the phenome-wide association analysis in the total sample. The horizontal 
red line indicates the threshold of p=0.002; the horizontal blue line indicates the threshold of p=0.05, phenotypes 
found below the blue line (p>0.05 – not associated) are not annotated in the plots to avoid noise. The triangle 
tip direction represents the odds ratio direction of each association, upward triangles indicate OR ≥ 1; 
downward triangles indicate a protective effect (OR < 1.0); different triangle colors indicate different disease 
groups (from left to right – dark green=neoplasms, dark blue=neurological system, bright red=circulatory 
system, brown=respiratory, green=digestive, dark red=dermatologic and light blue=congenital anomalies). (a) 
AXIN2 - rs11867417 and its association with glossitis (p<0.002). (b)  AXIN2 - rs2240308 and its protective effect 
towards having gingivitis, chronic periodontitis, and leukoplakia of the oral mucosa (p<0.05). (c) RHEB - 
rs1109089 and its association with both disorders of tooth development (p<0.05), and tooth fracture (p<0.002), 




















Figure 4. Plot representing the phenome-wide association analysis in the cancer-affected sample. The 
horizontal red line indicates the threshold of p=0.002; the horizontal blue line indicates the threshold of p=0.05, 
phenotypes found below the blue line (p>0.05 – not associated) are not annotated in the plots to avoid noise. 
The triangle tip direction represents the odds ratio direction of each association, upward triangles indicate OR 
≥ 1; downward triangles indicate a protective effect (OR < 1.0); different triangle colors indicate different 
disease groups (from left to right – light red=circulatory system, green=digestive, dark red=dermatologic and 
light blue=congenital anomalies). (a) AXIN2 - rs11867417 and its association with loss of teeth/edentulism, and 
its protective effect towards gingivitis (p<0.05). (b) AXIN2 - rs2240308 and its association with loss of 
teeth/edentulism and its protective effect against leukoplakia of the oral mucosa (p<0.05). (c) RHEB - rs1109089 




Here we report an analysis of a cohort enriched with individuals diagnosed with cancer 
using PheWAS in an attempt to identify oral health outcomes and genetic variants that may be 
indicators of cancer risk. Nominal associations were found when the cancer-affected patients were 
analyzed separately. For both SNPs in RHEB, the less frequent alleles appeared to be protective of 
having periodontitis in the cancer diagnosed individuals, and having anomalies of jaw size/ 
symmetry in the total sample. Both RHEB and RPTOR genes are present in the signaling pathway 
known as the mammalian target of rapamycin (mTOR). The mTOR signaling is a master regulator 
of protein synthesis, RHEB (Ras homolog enriched in brain) is a positive regulator of mTOR and 
is located in the center of the signaling pathway (Sciarretta et al. 2018). RPTOR (the Regulatory 
Associated Protein of mTOR) regulates cell growth in response to nutrient and insulin levels 
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(Sabatini 2017). Activation of mTOR promotes tumor growth and metastasis (Hua et al. 
2019). Rptor knockout mice display facial growth deficiency, including mandible (Schachter et al. 
1985), which is consistent with our finding.  
Unique associations were also identified for a number of other markers in the cancer-
affected group; two markers in AXIN2 and loss of teeth/edentulism and a marker in RHEB and 
leukoplakia of the oral mucosa showed associations.  AXIN2 is a component of Wnt signaling and 
is expressed in the dental mesenchyme, dental papilla and enamel knot (X. Wu et al. 2017). The 
AXIN2 rs2240308 polymorphism results in an amino acid change from a proline to a serine 
(Pro50Ser) located at exon 1 148 of this gene and has been suggested to influence AXIN expression 
(Z. Wu et al. 2015). This SNP has also been suggested as a risk marker for colorectal cancer 
predisposition (Otero et. Al 2019). Authors of another article proposed the mechanism causing 
colorectal cancer being mutations in AXIN2 with mismatch repair by activating beta-catenin/ TCF 
signaling (Liu et al. 2000). A recent study reported that Axin2 cells maintain expression in 
cementoblasts in adult mice. Their results showed that cells in mice’s periodontal ligament 
receiving Wnt signals differentiated into cementoblasts during homeostasis (Zhao et al. 2021), and 
another study concluded that Wtn signaling is essential for new cementum deposition and lesion 
repair (Turkkahraman et al. 2021). It might be plausible to suggest that change in AXIN expression 
could be disrupting homeostasis and cementoblast replenishment, leading to higher susceptibility 
to tooth loss due to periodontitis in the cancer-affected individuals in a similar way that it increases 
predisposition to colorectal cancer. More specifically, increased levels of b catenin in the cell 
caused by an impaired degradation complex and increased canonical Wtn signaling could be 
affecting self-renewal and periodontal ligament stem cells differentiation as a mechanism proposed 
for stem cells before (Yang et al. 2015). Cementoblast differentiation is not fully understood 
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(Nemoto et al. 2015) but altered differentiation in those cells could be impacting proper cellular 
cementum deposition. A study showed an absence of transcripts of bone sialoprotein in follicle 
mesenchyme as a composition change observed in disrupted cementogenesis (Zhang et al. 2013). 
This disruption in cementum structure could be affecting the entire periodontium complex, 
increasing susceptibility to bacterial apposition, growth and consequently inflammation. Tissue 
remodeling and bone resorption will then occur, making one more susceptible to tooth loss. This 
mechanism is supported by the opposite results found in the group of patients who had never 
received a cancer diagnosis. This group presented an association between the same SNP (AXIN2 
rs2240308) and lower risk of developing gingivitis which is a milder form of gum disease that can 
evolve to periodontitis.  
We suggest that the association between RHEB and leukoplakia, which is associated with 
increased risk of oral cancer, has to do with inflammation and regulation of RHEB/mTOR 
signaling. A study performed in mice, showed that loss of Rheb in macrophages repressed 
inflammation, whereas overexpression of this same gene increased inflammation (Zhang et al. 
2019). In our study, most of the glossitis affected individuals presented geographic tongue and 
disruption in inflammatory response pathways might be the most explainable mechanism for the 
association between AXIN2 rs11867417 SNP and glossitis as well.  
Our results suggest a role of AXIN2 in tooth loss. Previous studies have shown an 
association between AXIN2 and tooth agenesis (Callahan et al. 2009; Mostowska, Biedziak, and 
Jagodzinski 2006) and in our study we cannot discard the possibility of a missing tooth due to 
agenesis being reported as tooth loss if the patient had that missing tooth prior to the start of the 
treatment in the dental school. However, that possibility is low due to the prevalence of tooth 
agenesis varying from 2.2 to 10.1% (Bozga, Stanciu, and Manuc 2014).  
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No significant associations were found when analyzing the cancer-affected group in 
separate (after Bonferroni correction). This may be due to the reduced power of the smaller sample 
size of the cancer-affected group. Nevertheless, the p-values below 0.00025 set after Bonferroni 
correction may be too strict especially if we consider that some of the oral phenotypes might be 
related. Examples of these include most cases of periapical lesions which are caused by dental 
caries, or gingivitis that can evolve to periodontitis. This strict multiple testing correction may lead 
to missing true biological signals (Vieira et al. 2008). 
The phenotype-to-phenotype analysis showed an association between having had tooth loss 
and having been diagnosed with cancer, consistent with the results obtained in the PheWAS 
analysis. Since not only tooth loss/edentulism but also leukoplakia of oral mucosa are examples of 
phenotypes that showed associated in individuals diagnosed with cancers, different types of 
cancers could be better defined to confirm if these oral health outcomes associate. Similarly, when 
genetic variation was analyzed as potential risk markers in the total sample, some of the results 
after correction for multiple testing suggest that the risk alleles are not overrepresented among 
individuals affected by cancer, making it difficult to use those specific phenotypes as markers of 
risk. 
This is the first time that a phenome-wide study has been performed using a dental database 
and we demonstrated the applicability of the technique to the dental field and dental researchers 
for future studies. However, a few limitations were experienced. We were not able to differentiate 
between losing one tooth, including third molars, and losing all teeth (edentulism). Refining these 
and other phenotypes in future studies, is an approach that will help clarify if edentulism, which is 
an extreme outcome, is a risk marker for cancer. A previous meta-analysis performed with the 
intention of seeking for association between oral health and colorectal cancer included studies that 
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took into account the number of teeth lost. Subjects with no teeth lost, 1-8 or 9-20 teeth lost were 
compared with subjects who had more than 20 teeth lost due to dental caries and/or periodontitis. 
They concluded that there was a lack of evidence for association between oral health and colorectal 
cancer risk (Ren et al. 2016). Nonetheless, in their methodology, the number and reason for tooth 
loss was self-reported which constitutes a great limitation of the study since not always the patient 
remembers how many teeth he lost and what specific reason led to tooth extraction other than pain. 
The second limitation we faced here is that the types of cancer present in our study sample 
are not representative of the most frequent cancers in the general population. Lung cancer, for 
example, is the second most common cancer, for both men and women. However, in our Dental 
Registry and DNA Repository project, only ten subjects (four males and six females) reported 
having lung cancer. The reason for this difference might be explained by the high mortality rate of 
lung cancer in patients. For a patient to participate in the Dental Registry and DNA Repository 
project and report having had cancer, they either survived the disease or are undergoing treatment. 
Therefore, there is a higher probability that these individuals had a type of cancer with a low five-
year survival rate and were not captured in our sample. Further, ideally, we would be able to 
replicate our work in another cohort, but our project is the only one in the world that includes over 
40 specific oral phenotypes that were diagnosed by a careful dental exam. Dental phenotypes 
especially are typically omitted from such studies since they are not part of medical records. 
Analyses were done taking into consideration sex and ethnicity. Females and males share 
a genome but differ in almost every phenotype (Cheng and Kirkpatrick 2017), including oral health 
outcomes such as dental caries (Deeley et al. 2008). We used self-reported ethnicity as an 
adjustment in the regression analysis, and we are aware that there are instances that some self-
identified African Americans may have a high percentage of European ancestry, whereas some 
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self-identified European Americans have substantial admixture from African ancestry (Mersha and 
Abebe 2015). To mitigate the potential effect of population substructure, ancestry may be derived 
from genetic data. Our previous experience with the data from the Dental Registry and DNA 
Repository project suggests that there is good consistency between self-reported and genetically 
driven ethnicity definitions (Feng et al. 2014). Comparisons between estimates of genetic ancestry 
and self-reported ethnicity in African and European American populations from 1000 genomes 
project datasets showed that European ancestry estimations from genetic data was 97.6% for 
individuals that self-reported as Europeans, only 1.3% for individuals that self-reported as 
Africans, and 10.8% for individuals that self-reported as African Americans (Mersha and Abebe 
2015). The analysis could also not account for known factors that modify oral health outcomes. 
We did not include a surrogate for socioeconomic status in the analysis, however the participants 
of our Dental Registry and DNA Repository project are for the most part, from lower 
socioeconomic status and have poor oral and overall health outcomes (Vieira, Hilands, and Braun 
2015). We also could not include a measure for the potential consequence of cancer on the patient’s 
oral health. Cancer treatment can be as devastating as the disease itself, with the aggravating factor 
that dentists can be perceived as less knowledgeable about cancer treatment-related oral concerns 
and therefore trusted less than oncologists (Taichman, Van Poznak, and Inglehart 2018; Epstein 
and Barasch 2018). 
In summary, previously suggested associations in the studied genes were consistent with 
our findings and novel potential associations were identified. Tooth loss/edentulism was associated 
with two AXIN2 SNPs in the cancer-affected sample, increasing up to 2.3 times the chances of 
losing teeth. The phenotype-to-phenotype analysis showed similar results, confirming that 
individuals diagnosed with cancer experience more tooth loss. This particular association could be 
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just the result of the cancer itself, since most of the cancer diagnosed patients have 
immunosuppression, which consequently may lead to tooth loss. However, one should consider 
that a particular phenotype that is the result of a person’s cancer still may be more likely to be 
identified prior to the cancer itself being identified. Individuals with immune system disorders, 
such as Dubowitz or Down syndromes, show characteristic facies and dental abnormalities and 
higher incidence of leukemia/lymphoma (Joshi, Hamdan, and Fakhouri 2014). 
This study implemented a novel strategy to identify cancer risk markers by combining 
electronic health records and genetics. Identification of individuals carrying craniofacial and 
genetic markers allow dentists to refer them for screenings/checkups more frequently. This 
conduct potentially increases the possibility of preventing cancers or diagnosing them at early 
stages when the treatment survival rates are higher.  
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 CONCLUSIONS AND FUTURE DIRECTIONS 
We first concluded that variation in both mTOR and ER stress genes showed to be 
associated with osteoporosis, and variation in mTOR genes were associated with periapical lesions 
and dental caries. Additionally, different associations in both pathways were detected when oral 
conditions were analyzed in combination (Bezamat et al. 2019). However, these combined-disease 
associations were not always more significant than the ones in the isolated-disease analysis as we 
hypothesized. We then, concluded that previously suggested associations in the studied genes were 
consistent with our findings and novel associations were identified. We confirmed that there is a 
range of orofacial phenotypes nominally associated with cancer both indirectly, such as tooth 
fracture, glossitis and temporomandibular joint disorder through cancer associated genes and 
directly such as tooth loss/edentulism through the phenotype-phenotype analysis (Bezamat et al. 
2020). These orofacial phenotypes can potentially serve as cancer risk markers. The results showed 
tooth loss and edentulism associated with cancer in both a phenotype-to-phenotype analysis and 
phenotype-genotype analysis.  
Our study is the first of its kind to conduct a PheWAS in cancer affected patients with the 
intention of finding both genetic and orofacial phenotypic markers for cancer experience. Future 
studies could include an increased sample of cancer affected individuals to consequently increase 
statistical power and detect significant associations. Collaborations with different dental schools 
and centers are warranted in order to include oral heath indicators that are measured by dental 
health professionals instead of the vastly used self-reported outcomes. Including a greater sample 
size will also allow for individualized analyses of different types of cancer, improving the 
possibility of early diagnosis. Another suggested future work could define the time at cancer 
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diagnosis regarding the appearance of each orofacial phenotype indicating if a specific trait could 
serve as a risk marker. This can be done by performing a prospective cohort study or even a 
retrospective study using the cohort we used here. The DRDR database allows for some 
longitudinal research in subjects who have been treated in our dental school for a long period of 
time. With that, we can jump back in time and identify available data regarding cancer diagnosis 
of those particular individuals. Additionally, the DRDR study includes a signed consent form with 
the possibility of future contact, which authorize investigators to call or email the subjects and 
obtain missing data. That can be done for those subjects that information regarding the time at 
cancer diagnosis are missing in the database.  
Finally, a next step could involve the inclusion of many additional SNPs in candidate genes 
or even the conduction of a PheGWAS which combines both GWAS and PheWAS approaches 
utilizing the “many variants-many phenotypes” scenario. The PheGWAS technique might assist 
in detecting pleiotropy at a genome-wide scale (George et al. 2020) allowing us to explore a vast 




Appendix A  
Table 12.  Full results of association tests for selected SNPs and disease phenotypes isolated and combined. 
Assuming that D is the minor allele and d is the major allele, the allelic model compares the frequencies of each 
allele in each group (D x d), the genotypic model is an additive two degree of freedom model that compares the 
frequency of each genotype in each group (DD x Dd x dd), the trend is the Cochran-Armitage test that does not 
assume Hardy-Weinberg equilibrium, the dominant model compares the two copies of the common allele 
versus the sum of the other combinations in each group (dd x DD + Dd), and the recessive model compares the 
two copies of the rare allele frequency versus the sum other combinations in each group (DD x Dd + dd). DF = 
degrees of freedom. 
 
Dental caries 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected        X2.       DF     P-value 
  17   rs1012117    A    G     GENO     41/220/221     81/345/345        1.351    2        0.509 
  17   rs1012117    A    G    TREND        302/662       507/1035       0.6743    1       0.4115 
  17   rs1012117    A    G  ALLELIC        302/662       507/1035       0.6532    1        0.419 
  17   rs1012117    A    G      DOM        261/221        426/345       0.1458    1       0.7025 
  17   rs1012117    A    G      REC         41/441         81/690        1.349    1       0.2454 
  1    rs1010447    T    C     GENO     68/242/253    110/378/363       0.7575    2       0.6847 
  1    rs1010447    T    C    TREND        378/748       598/1104        0.713    1       0.3985 
  1    rs1010447    T    C  ALLELIC        378/748       598/1104       0.7343    1       0.3915 
  1    rs1010447    T    C      DOM        310/253        488/363       0.7178    1       0.3969 
  1    rs1010447    T    C      REC         68/495        110/741       0.2213    1        0.638 
  9    rs1050700    C    T     GENO     49/213/201     77/325/323       0.1699    2       0.9186 
  9    rs1050700    C    T    TREND        311/615        479/971      0.07885    1       0.7789 
  9    rs1050700    C    T  ALLELIC        311/615        479/971      0.07726    1       0.7811 
  9    rs1050700    C    T      DOM        262/201        402/323       0.1487    1       0.6997 
  9    rs1050700    C    T      REC         49/414         77/648    0.0004199    1       0.9837 
  16   rs1051771    C    G     GENO       3/72/441       6/98/682        0.737    2       0.6917 
  16   rs1051771    C    G    TREND         78/954       110/1462       0.2851    1       0.5933 
  16   rs1051771    C    G  ALLELIC         78/954       110/1462       0.2924    1       0.5887 
  16   rs1051771    C    G      DOM         75/441        104/682        0.494    1       0.5041 
  16   rs1051771    C    G      REC          3/513          6/780        0.150    1       0.6983 
  7    rs1109089    T    C     GENO    106/232/183    172/378/254        1.786    2       0.4095 
  7    rs1109089    T    C    TREND        444/598        722/886        1.263    1       0.2611 
  7    rs1109089    T    C  ALLELIC        444/598        722/886        1.346    1        0.246 
  7    rs1109089    T    C      DOM        338/183        550/254        1.785    1       0.1815 
  7    rs1109089    T    C      REC        106/415        172/632       0.2092    1       0.6474 
  1   rs11121718    C    T     GENO       3/27/490       5/51/763        0.629    2       0.7299 
  1   rs11121718    C    T    TREND        33/1007        61/1577       0.5001    1       0.4794 
  1   rs11121718    C    T  ALLELIC        33/1007        61/1577       0.5702    1       0.4502 
  1   rs11121718    C    T      DOM         30/490         56/763        0.604    1       0.4370 
  1   rs11121718    C    T      REC          3/517          5/814        0.006    1       0.9380 
  1   rs11580061    G    A     GENO       0/34/451       3/64/686        2.873    2       0.2377 
  1   rs11580061    G    A    TREND         34/936        70/1436        1.884    1       0.1698 
 lxxii 
  1   rs11580061    G    A  ALLELIC         34/936        70/1436        1.915    1       0.1664 
  1   rs11580061    G    A      DOM         34/451         67/686        1.403    1       0.2319 
  1   rs11580061    G    A      REC          0/485          3/750       3.112    1       0.0777 
  17  rs11655020    A    G     GENO     40/256/240     73/441/303        8.037    2      0.01798 
  17  rs11655020    A    G    TREND        336/736       587/1047        7.078    1     0.007806 
  17  rs11655020    A    G  ALLELIC        336/736       587/1047        6.044    1      0.01396 
  17  rs11655020    A    G      DOM        296/240        514/303        7.965    1      0.00477 
  17  rs11655020    A    G      REC         40/496         73/744       0.9168    1       0.3383 
  17  rs11651724    A    G     GENO     21/112/170     18/160/353        11.24    2     0.003619 
  17  rs11651724    A    G    TREND        154/452        196/866        11.08    1    0.0008728 
  17  rs11651724    A    G  ALLELIC        154/452        196/866        11.26    1     0.000791 
  17  rs11651724    A    G      DOM        133/170        178/353        8.876    1     0.002889 
  17  rs11651724    A    G      REC         21/282         18/513        5.426    1      0.01984 
  5    rs1239265    A    T     GENO       4/16/287       2/22/329        1.278    2       0.5278 
  5    rs1239265    A    T    TREND         24/590         26/680      0.03806    1       0.8453 
  5    rs1239265    A    T  ALLELIC         24/590         26/680      0.04606    1       0.8301 
  5    rs1239265    A    T      DOM         20/287         24/329        0.021    1       0.8839 
  5    rs1239265    A    T      REC          4/303          2/351        0.988    1       0.3201 
  5   rs13166875    G    A     GENO     54/175/168     93/264/270       0.5092    2       0.7752 
  5   rs13166875    G    A    TREND        283/511        450/804      0.01169    1       0.9139 
  5   rs13166875    G    A  ALLELIC        283/511        450/804      0.01248    1       0.9111 
  5   rs13166875    G    A      DOM        229/168        357/270      0.05509    1       0.8144 
  5   rs13166875    G    A      REC         54/343         93/534       0.2994    1       0.5843 
  5    rs1423688    G    T     GENO     63/197/183    109/280/290         1.37    2        0.504 
  5    rs1423688    G    T    TREND        323/563        498/860     0.009911    1       0.9207 
  5    rs1423688    G    T  ALLELIC        323/563        498/860      0.01074    1       0.9175 
  5    rs1423688    G    T      DOM        260/183        389/290       0.2157    1       0.6424 
  5    rs1423688    G    T      REC         63/380        109/570       0.6931    1       0.4051 
  17  rs16947425    A    C     GENO     18/130/353     16/219/546        3.248    2       0.1971 
  17  rs16947425    A    C    TREND        166/836       251/1311        0.111    1        0.739 
  17  rs16947425    A    C  ALLELIC        166/836       251/1311        0.111    1        0.739 
  17  rs16947425    A    C      DOM        148/353        235/546      0.04386    1       0.8341 
  17  rs16947425    A    C      REC         18/483         16/765        2.819    1      0.09316 
  17   rs1874087    T    C     GENO    139/208/177    220/337/259       0.6319    2       0.7291 
  17   rs1874087    T    C    TREND        486/562        777/855       0.3306    1       0.5653 
  17   rs1874087    T    C  ALLELIC        486/562        777/855       0.3914    1       0.5315 
  17   rs1874087    T    C      DOM        347/177        557/259        0.604    1        0.437 
  17   rs1874087    T    C      REC        139/385        220/596      0.03065    1        0.861 
  17    rs196950    T    C     GENO     99/182/242    146/282/381       0.1808    2       0.9136 
  17    rs196950    T    C    TREND        380/666       574/1044       0.1619    1       0.6874 
  17    rs196950    T    C  ALLELIC        380/666       574/1044       0.2011    1       0.6538 
  17    rs196950    T    C      DOM        281/242        428/381      0.08656    1       0.7686 
  17    rs196950    T    C      REC         99/424        146/663       0.1647    1       0.6848 
  17    rs196929    T    C     GENO     64/178/231     99/299/347       0.7866    2       0.6748 
  17    rs196929    T    C    TREND        306/640        497/993       0.2393    1       0.6247 
  17    rs196929    T    C  ALLELIC        306/640        497/993       0.2666    1       0.6056 
  17    rs196929    T    C      DOM        242/231        398/347       0.5926    1       0.4414 
  17    rs196929    T    C      REC         64/409         99/646      0.01462    1       0.9037 
  5    rs2043112    A    G     GENO     75/230/201    131/314/315        2.521    2       0.2835 
  5    rs2043112    A    G    TREND        380/632        576/944      0.02839    1       0.8662 
  5    rs2043112    A    G  ALLELIC        380/632        576/944      0.03083    1       0.8606 
  5    rs2043112    A    G      DOM        305/201        445/315       0.3739    1       0.5409 
  5    rs2043112    A    G      REC         75/431        131/629          1.3    1       0.2542 
  16   rs2073636    A    G     GENO     60/243/205    101/336/342         2.75    2       0.2529 
  16   rs2073636    A    G    TREND        363/653       538/1020       0.3829    1       0.5361 
  16   rs2073636    A    G  ALLELIC        363/653       538/1020       0.3872    1       0.5338 
  16   rs2073636    A    G      DOM        303/205        437/342        1.584    1       0.2082 
  16   rs2073636    A    G      REC         60/448        101/678       0.3743    1       0.5406 
  22   rs2097461    C    T     GENO     79/231/226    120/340/350       0.1794    2       0.9142 
  22   rs2097461    C    T    TREND        389/683       580/1040      0.06099    1       0.8049 
  22   rs2097461    C    T  ALLELIC        389/683       580/1040      0.06582    1       0.7975 
  22   rs2097461    C    T      DOM        310/226        460/350       0.1441    1       0.7043 
  22   rs2097461    C    T      REC         79/457        120/690     0.001479    1       0.9693 
 lxxiii 
  22   rs2239815    C    T     GENO     86/224/220    150/332/329        1.144    2       0.5645 
  22   rs2239815    C    T    TREND        396/664        632/990       0.6227    1       0.4301 
  22   rs2239815    C    T  ALLELIC        396/664        632/990       0.6993    1        0.403 
  22   rs2239815    C    T      DOM        310/220        482/329       0.1177    1       0.7316 
  22   rs2239815    C    T      REC         86/444        150/661        1.138    1        0.286 
  17   rs2289764    C    T     GENO     51/182/271    100/272/370        3.707    2       0.1567 
  17   rs2289764    C    T    TREND        284/724       472/1012        3.291    1      0.06964 
  17   rs2289764    C    T  ALLELIC        284/724       472/1012        3.745    1      0.05295 
  17   rs2289764    C    T      DOM        233/271        372/370        1.832    1       0.1759 
  17   rs2289764    C    T      REC         51/453        100/642        3.178    1      0.07464 
  7    rs2299967    T    C     GENO    125/263/137    186/399/239         1.37    2       0.5042 
  7    rs2299967    T    C    TREND        513/537        771/877        1.088    1        0.297 
  7    rs2299967    T    C  ALLELIC        513/537        771/877        1.105    1       0.2931 
  7    rs2299967    T    C      DOM        388/137        585/239         1.35    1       0.2452 
  7    rs2299967    T    C      REC        125/400        186/638       0.2765    1        0.599 
  7    rs2374261    T    C     GENO    105/211/192    162/344/245        3.705    2       0.1568 
  7    rs2374261    T    C    TREND        421/595        668/834        2.067    1       0.1505 
  7    rs2374261    T    C  ALLELIC        421/595        668/834        2.277    1       0.1313 
  7    rs2374261    T    C      DOM        316/192        506/245        3.577    1      0.05859 
  7    rs2374261    T    C      REC        105/403        162/589       0.1475    1       0.7009 
  7    rs3753151    C    T     GENO     86/185/145    115/292/213       0.9701    2       0.6157 
  7    rs3753151    C    T    TREND        357/475        522/718       0.1271    1       0.7215 
  7    rs3753151    C    T  ALLELIC        357/475        522/718       0.1344    1       0.7139 
  7    rs3753151    C    T      DOM        271/145        407/213      0.02762    1        0.868 
  7    rs3753151    C    T      REC         86/330        115/505       0.7187    1       0.3966 
  17   rs4255830    G    A     GENO    134/243/139    204/384/220      0.08635    2       0.9577 
  17   rs4255830    G    A    TREND        511/521        792/824      0.06119    1       0.8046 
  17   rs4255830    G    A  ALLELIC        511/521        792/824      0.06442    1       0.7996 
  17   rs4255830    G    A      DOM        377/139        588/220      0.01338    1       0.9079 
  17   rs4255830    G    A      REC        134/382        204/604      0.08622    1        0.769 
  17   rs4396582    G    A     GENO    134/252/141    192/372/238        1.377    2       0.5023 
  17   rs4396582    G    A    TREND        520/534        756/848        1.168    1       0.2798 
  17   rs4396582    G    A  ALLELIC        520/534        756/848        1.237    1        0.266 
  17   rs4396582    G    A      DOM        386/141        564/238        1.331    1       0.2487 
  17   rs4396582    G    A      REC        134/393        192/610       0.3797    1       0.5377 
  16   rs7187438    C    T     GENO     96/256/178    144/399/267       0.1175    2       0.9429 
  16   rs7187438    C    T    TREND        448/612        687/933     0.005392    1       0.9415 
  16   rs7187438    C    T  ALLELIC        448/612        687/933     0.005386    1       0.9415 
  16   rs7187438    C    T      DOM        352/178        543/267      0.05587    1       0.8131 
  16   rs7187438    C    T      REC         96/434        144/666      0.02452    1       0.8756 
Periodontal disease 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected        X2.        DF     P-value 
   5   rs2043112    A    G     GENO          6/8/7      45/103/91        1.162    2       0.5592 
   5   rs2043112    A    G    TREND          20/22        193/285       0.7495    1       0.3866 
   5   rs2043112    A    G  ALLELIC          20/22        193/285       0.8374    1       0.3601 
   5   rs2043112    A    G      DOM           14/7         148/91       0.1848    1       0.6673 
   5   rs2043112    A    G      REC           6/15         45/194        1.162    1        0.281 
   5   rs1239265    A    T     GENO         0/5/43      12/35/213        2.791    2       0.2477 
   5   rs1239265    A    T    TREND           5/91         59/461        2.518    1       0.1126 
   5   rs1239265    A    T  ALLELIC           5/91         59/461        3.279    1      0.07016 
   5   rs1239265    A    T      DOM           5/43         47/213        1.694    1       0.1930 
   5   rs1239265    A    T      REC           0/48         12/248        2.305    1       0.1289 
   5  rs13166875    G    A     GENO         6/8/10       19/58/73        2.558    2       0.2783 
   5  rs13166875    G    A    TREND          20/28         96/204        1.518    1        0.218 
   5  rs13166875    G    A  ALLELIC          20/28         96/204         1.74    1       0.1871 
   5  rs13166875    G    A      DOM          14/10          77/73       0.4064    1       0.5238 
   5  rs13166875    G    A      REC           6/18         19/131        2.558    1       0.1097 
   5   rs1423688    G    T     GENO        4/10/17      30/92/102        1.039    2       0.5949 
   5   rs1423688    G    T    TREND          18/44        152/296       0.5341    1       0.4649 
   5   rs1423688    G    T  ALLELIC          18/44        152/296       0.5876    1       0.4434 
   5   rs1423688    G    T      DOM          14/17        122/102        0.947    1       0.3305 
   5   rs1423688    G    T      REC           4/27         30/194        0.006    1       0.9400 
 lxxiv 
   7   rs1109089    T    C     GENO        7/20/25     52/116/107        1.775    2       0.4116 
   7   rs1109089    T    C    TREND          34/70        220/330        1.748    1       0.1861 
   7   rs1109089    T    C  ALLELIC          34/70        220/330        1.966    1       0.1608 
   7   rs1109089    T    C      DOM          27/25        168/107        1.527    1       0.2166 
   7   rs1109089    T    C      REC           7/45         52/223       0.8776    1       0.3489 
   7   rs3753151    C    T     GENO       10/21/13      46/120/75       0.3129    2       0.8552 
   7   rs3753151    C    T    TREND          41/47        212/270       0.2054    1       0.6504 
   7   rs3753151    C    T  ALLELIC          41/47        212/270        0.205    1       0.6507 
   7   rs3753151    C    T      DOM          31/13         166/75      0.04324    1       0.8353 
   7   rs3753151    C    T      REC          10/34         46/195       0.3123    1       0.5763 
   7   rs2299967    T    C     GENO       14/22/15      68/141/69        1.011    2       0.6033 
   7   rs2299967    T    C    TREND          50/52        277/279       0.0219    1       0.8824 
   7   rs2299967    T    C  ALLELIC          50/52        277/279      0.02209    1       0.8818 
   7   rs2299967    T    C      DOM          36/15         209/69       0.4779    1       0.4894 
   7   rs2299967    T    C      REC          14/37         68/210        0.206    1       0.6499 
   7   rs2374261    T    C     GENO        8/19/21     50/109/102       0.4025    2       0.8177 
   7   rs2374261    T    C    TREND          35/61        209/313       0.3838    1       0.5356 
   7   rs2374261    T    C  ALLELIC          35/61        209/313       0.4349    1       0.5096 
   7   rs2374261    T    C      DOM          27/21        159/102        0.369    1       0.5436 
   7   rs2374261    T    C      REC           8/40         50/211       0.1649    1       0.6847 
   9   rs1050700    C    T     GENO       10/19/14      42/81/118        3.949    2       0.1388 
   9   rs1050700    C    T    TREND          39/47        165/317        3.172    1      0.07489 
   9   rs1050700    C    T  ALLELIC          39/47        165/317        3.918    1      0.04776 
   9   rs1050700    C    T      DOM          29/14        123/118        3.947    1      0.04694 
   9   rs1050700    C    T      REC          10/33         42/199       0.8287    1       0.3626 
  16   rs2073636    A    G     GENO        5/16/19     29/101/103       0.1722    2       0.9175 
  16   rs2073636    A    G    TREND          26/54        159/307      0.07667    1       0.7819 
  16   rs2073636    A    G  ALLELIC          26/54        159/307         0.08    1       0.7773 
  16   rs2073636    A    G      DOM          21/19        130/103       0.1499    1       0.6987 
  16   rs2073636    A    G      REC           5/35         29/204   9.012e-005    1       0.9924 
  16   rs7187438    C    T     GENO       14/22/14      56/115/84       0.9932    2       0.6086 
  16   rs7187438    C    T    TREND          50/50        227/283       0.9293    1       0.3351 
  16   rs7187438    C    T  ALLELIC          50/50        227/283        1.017    1       0.3133 
  16   rs7187438    C    T      DOM          36/14         171/84        0.468    1       0.4939 
  16   rs7187438    C    T      REC          14/36         56/199       0.8622    1       0.3531 
  16   rs1051771    C    G     GENO         0/1/41        3/0/157        4.598    2       0.1003 
  16   rs1051771    C    G    TREND           1/83          6/314      0.09873    1       0.7534 
  16   rs1051771    C    G  ALLELIC           1/83          6/314       0.1831    1       0.6687 
  16   rs1051771    C    G      DOM           1/41          3/157        0.044    1       0.8340 
  16   rs1051771    C    G      REC           0/42          3/157        0.799    1       0.3712 
  17    rs196929    T    C     GENO       14/15/12       37/86/93        6.723    2      0.03468 
  17    rs196929    T    C    TREND          43/39        160/272        5.809    1      0.01594 
  17    rs196929    T    C  ALLELIC          43/39        160/272        6.842    1     0.008906 
  17    rs196929    T    C      DOM          29/12         123/93        2.711    1      0.09967 
  17    rs196929    T    C      REC          14/27         37/179        6.273    1      0.01226 
  17  rs16947425    A    C     GENO        2/14/40       9/69/197        0.013    2       0.9935 
  17  rs16947425    A    C    TREND          18/94         87/463     0.004217    1       0.9482 
  17  rs16947425    A    C  ALLELIC          18/94         87/463     0.004472    1       0.9467 
  17  rs16947425    A    C      DOM          16/40         78/197        0.001    1       0.9749 
  17  rs16947425    A    C      REC           2/54          9/266        0.013    1       0.9095 
  17    rs196950    T    C     GENO       20/17/19      66/84/116        3.115    2       0.2107 
  17    rs196950    T    C    TREND          57/55        216/316        2.955    1       0.0856 
  17    rs196950    T    C  ALLELIC          57/55        216/316        4.013    1      0.04516 
  17    rs196950    T    C      DOM          37/19        150/116         1.78    1       0.1821 
  17    rs196950    T    C      REC          20/36         66/200        2.809    1      0.09374 
  17   rs1874087    C    T     GENO        18/18/8       44/57/56        5.345    2      0.06907 
  17   rs1874087    C    T    TREND          54/34        145/169        5.058    1      0.02452 
  17   rs1874087    C    T  ALLELIC          54/34        145/169        6.341    1       0.0118 
  17   rs1874087    C    T      DOM           36/8         101/56        4.843    1      0.02777 
  17   rs1874087    C    T      REC          18/26         44/113        2.674    1        0.102 
  17  rs11655020    A    G     GENO        1/11/38      11/29/224        4.915    2       0.0856 
  17  rs11655020    A    G    TREND          13/87         51/477       0.7862    1       0.3752 
  17  rs11655020    A    G  ALLELIC          13/87         51/477        1.025    1       0.3113 
 lxxv 
  17  rs11655020    A    G      DOM          12/38         40/224        2.382    1       0.1227 
  17  rs11655020    A    G      REC           1/49         11/253        0.537    1       0.4637 
  17   rs4255830    A    G     GENO       10/27/16      76/131/73        1.627    2       0.4434 
  17   rs4255830    A    G    TREND          47/59        283/277        1.302    1       0.2538 
  17   rs4255830    A    G  ALLELIC          47/59        283/277        1.369    1        0.242 
  17   rs4255830    A    G      DOM          37/16         207/73       0.3858    1       0.5345 
  17   rs4255830    A    G      REC          10/43         76/204        1.593    1       0.2069 
  17   rs4396582    G    A     GENO        8/18/20      54/118/91        1.344    2       0.5106 
  17   rs4396582    G    A    TREND          34/58        226/300        1.058    1       0.3038 
  17   rs4396582    G    A  ALLELIC          34/58        226/300         1.16    1       0.2814 
  17   rs4396582    G    A      DOM          26/20         172/91         1.34    1       0.2469 
  17   rs4396582    G    A      REC           8/38         54/209       0.2408    1       0.6236 
  17  rs11651724    A    G     GENO         0/9/44      12/43/214        2.458    2       0.2926 
  17  rs11651724    A    G    TREND           9/97         67/471        1.091    1       0.2962 
  17  rs11651724    A    G  ALLELIC           9/97         67/471        1.336    1       0.2477 
  17  rs11651724    A    G      DOM           9/44         55/214        0.334    1       0.5634 
  17  rs11651724    A    G      REC           0/53         12/257        2.456    1       0.1170 
  17   rs2289764    C    T     GENO       11/17/14      36/80/114        4.594    2       0.1006 
  17   rs2289764    C    T    TREND          39/45        152/308        4.588    1      0.03219 
  17   rs2289764    C    T  ALLELIC          39/45        152/308        5.586    1      0.01811 
  17   rs2289764    C    T      DOM          28/14        116/114        3.756    1      0.05262 
  17   rs2289764    C    T      REC          11/31         36/194        2.759    1      0.09669 
  22   rs2097461    C    T     GENO        8/25/20     42/110/125        1.158    2       0.5604 
  22   rs2097461    C    T    TREND          41/65        194/360       0.4695    1       0.4932 
  22   rs2097461    C    T  ALLELIC          41/65        194/360       0.5202    1       0.4708 
  22   rs2097461    C    T      DOM          33/20        152/125       0.9865    1       0.3206 
  22   rs2097461    C    T      REC           8/45         42/235    0.0001606    1       0.9899 
  22   rs2239815    C    T     GENO       11/22/12     51/115/104        2.428    2       0.2971 
  22   rs2239815    C    T    TREND          44/46        217/323        2.182    1       0.1396 
  22   rs2239815    C    T  ALLELIC          44/46        217/323        2.408    1       0.1207 
  22   rs2239815    C    T      DOM          33/12        166/104        2.329    1        0.127 
  22   rs2239815    C    T      REC          11/34         51/219       0.7531    1       0.3855 
  17   rs1012117    A    G    GENO          8/2/5        35/7/29        0.36    2       0.8352 
  17   rs1012117    A    G   TREND          18/12          77/65        0.334    1       0.5633 
  17   rs1012117    A    G ALLELIC          18/12          77/65        0.334    1       0.5633 
  17   rs1012117    A    G     DOM           10/5          42/29        0.292    1       0.5887 
  17   rs1012117    A    G     REC            8/7          35/36        0.081    1       0.7762 
Periapical Lesions 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected        X2.       DF     P-value 
   5   rs1239265    A    T     GENO     10/42/42        2/6/124        68.38    2   5.461e-016      
   5   rs1239265    A    T    TREND       62/126         10/254        57.88    1   2.779e-014 
   5   rs1239265    A    T  ALLELIC       62/126         10/254        69.87    1   6.341e-017 
   5   rs1239265    A    T      DOM         52/42         8/124        68.31    1   4.231e-016      
   5   rs1239265    A    T      REC          10/84          2/130        9.089    1      0.00284 
   7   rs3753151    C    T     GENO        2/39/18       33/49/45        17.17    2      0.00019 
   7   rs3753151    C    T    TREND          43/75        115/139        2.495    1       0.1142 
   7   rs3753151    C    T  ALLELIC          43/75        115/139        2.574    1       0.1086 
   7   rs3753151    C    T      DOM          41/18          82/45        0.436    1       0.5069 
   7   rs3753151    C    T      REC           2/57          33/94       13.463    1      0.00024 
   7   rs2299967    C    T     GENO       17/38/20       36/63/36       0.4661    2       0.7921 
   7   rs2299967    C    T    TREND          72/78        135/135       0.1487    1       0.6998 
   7   rs2299967    C    T  ALLELIC          72/78        135/135       0.1543    1       0.6944 
   7   rs2299967    C    T      DOM          55/20          99/36   1.164e-031    1            1 
   7   rs2299967    C    T      REC          17/58          36/99       0.4088    1       0.5226 
   7   rs1109089    T    C     GENO       16/37/41       31/51/42        2.954    2       0.2283 
   7   rs1109089    T    C    TREND         69/119        113/135        2.952    1      0.08578 
   7   rs1109089    T    C  ALLELIC         69/119        113/135        3.454    1      0.06311 
   7   rs1109089    T    C      DOM          53/41          82/42        2.154    1       0.1422 
   7   rs1109089    T    C      REC          16/78          31/93        2.013    1        0.156 
   9   rs1050700    C    T     GENO        6/34/31       11/40/68        3.908    2       0.1417 
   9   rs1050700    C    T    TREND          46/96         62/176        1.687    1        0.194 
   9   rs1050700    C    T  ALLELIC          46/96         62/176        1.759    1       0.1847 
 lxxvi 
   9   rs1050700    C    T      DOM          40/31          51/68        3.238    1      0.07193 
   9   rs1050700    C    T      REC           6/65         11/108      0.03432    1        0.853 
  16   rs7187438    C    T     GENO       12/25/27       17/51/37        1.458    2       0.4823 
  16   rs7187438    C    T    TREND          49/79         85/125        0.151    1       0.6976 
  16   rs7187438    C    T  ALLELIC          49/79         85/125       0.1601    1        0.689 
  16   rs7187438    C    T      DOM          37/27          68/37       0.8162    1       0.3663 
  16   rs7187438    C    T      REC          12/52          17/88       0.1833    1       0.6686 
  16   rs2073636    A    G     GENO       11/40/47       17/54/42        2.599    2       0.2727 
  16   rs2073636    A    G    TREND         62/134         88/138        2.379    1        0.123 
  16   rs2073636    A    G  ALLELIC         62/134         88/138        2.445    1       0.1179 
  16   rs2073636    A    G      DOM          51/47          71/42        2.506    1       0.1134 
  16   rs2073636    A    G      REC          11/87          17/96       0.6653    1       0.4147 
  16   rs1051771    C    G     GENO        2/14/68       2/19/103        0.024    2       0.9883 
  16   rs1051771    C    G    TREND         18/150         23/225       0.2112    1       0.6459 
  16   rs1051771    C    G  ALLELIC         18/150         23/225       0.2338    1       0.6287 
  16   rs1051771    C    G      DOM          16/68         21/103        0.153    1       0.6959 
  16   rs1051771    C    G      REC           2/82          2/122        0.157    1       0.6922 
  17    rs196929    T    C     GENO       11/27/23       15/46/64        3.245    2       0.1974 
  17    rs196929    T    C    TREND          49/73         76/174        3.127    1      0.07702 
  17    rs196929    T    C  ALLELIC          49/73         76/174        3.503    1      0.06124 
  17    rs196929    T    C      DOM          38/23          61/64        2.999    1      0.08333 
  17    rs196929    T    C      REC          11/50         15/110        1.241    1       0.2653 
  17    rs196950    T    C     GENO       16/31/29       15/39/58        3.861    2       0.1451 
  17    rs196950    T    C    TREND          63/89         69/155        3.807    1      0.05104 
  17    rs196950    T    C  ALLELIC          63/89         69/155        4.503    1      0.03383 
  17    rs196950    T    C      DOM          47/29          54/58        3.382    1       0.0659 
  17    rs196950    T    C      REC          16/60          15/97        1.929    1       0.1649 
  17  rs16947425    A    C     GENO        1/19/43        5/27/93        2.237    2        0.326 
  17  rs16947425    A    C    TREND         21/105         37/213       0.2106    1       0.6463 
  17  rs16947425    A    C  ALLELIC         21/105         37/213       0.2238    1       0.6362 
  17  rs16947425    A    C      DOM          20/43          32/93        0.791    1       0.3738 
  17  rs16947425    A    C      REC           1/62          5/120        0.789    1       0.3743 
  17  rs11655020    A    G     GENO        2/13/82       1/13/118        1.499    2       0.4726 
  17  rs11655020    A    G    TREND         17/177         15/249         1.45    1       0.2285 
  17  rs11655020    A    G  ALLELIC         17/177         15/249        1.633    1       0.2012 
  17  rs11655020    A    G      DOM          15/82         14/118        1.193    1       0.2774 
  17  rs11655020    A    G      REC           2/95          1/131       0.736    1       0.3910 
  17   rs4255830    A    G     GENO       12/41/24       36/68/32        3.778    2       0.1512 
  17   rs4255830    A    G    TREND          65/89        140/132        3.466    1      0.06265 
  17   rs4255830    A    G  ALLELIC          65/89        140/132        3.379    1      0.06602 
  17   rs4255830    A    G      DOM          53/24         104/32        1.481    1       0.2237 
  17   rs4255830    A    G      REC          12/65         36/100        3.338    1      0.06771 
  17  rs11651724    A    G     GENO        4/15/43        2/22/92        3.738    2       0.1542 
  17  rs11651724    A    G    TREND         23/101         26/206        3.263    1      0.07084 
  17  rs11651724    A    G  ALLELIC         23/101         26/206        3.669    1      0.05542 
  17  rs11651724    A    G      DOM          19/43          24/92        2.186    1       0.1393 
  17  rs11651724    A    G      REC           4/58          2/114        2.772    1       0.0959 
  17   rs1012117    A    G     GENO        6/33/32       12/42/64        2.195    2       0.3338 
  17   rs1012117    A    G    TREND          45/97         66/170       0.5681    1        0.451 
  17   rs1012117    A    G  ALLELIC          45/97         66/170       0.5928    1       0.4413 
  17   rs1012117    A    G      DOM          39/32          54/64         1.49    1       0.2222 
  17   rs1012117    A    G      REC           6/65         12/106        0.152    1       0.6967 
  22   rs2239815    C    T     GENO        8/45/25       20/45/47        5.972    2      0.05049 
  22   rs2239815    C    T    TREND          61/95         85/139      0.05201    1       0.8196 
  22   rs2239815    C    T  ALLELIC          61/95         85/139      0.05195    1       0.8197 
  22   rs2239815    C    T      DOM          53/25          65/47         1.92    1       0.1659 
  22   rs2239815    C    T      REC           8/70          20/92        2.114    1        0.146 
  22   rs2097461    C    T     GENO        8/40/27       18/38/52        6.055    2      0.04844 
  22   rs2097461    C    T    TREND          56/94         74/142       0.3415    1        0.559 
  22   rs2097461    C    T  ALLELIC          56/94         74/142       0.3653    1       0.5456 
  22   rs2097461    C    T      DOM          48/27          56/52        2.663    1       0.1027 
  22   rs2097461    C    T      REC           8/67          18/90        1.307    1       0.2529 
  17   rs2289764    C    T     GENO       33/13/44      15/34/58        0.617    2       0.7345 
 lxxvii 
  17   rs2289764    C    T    TREND          79/93        64/150         10.5    1      0.00119 
  17   rs2289764    C    T  ALLELIC          79/93        64/150         10.5    1      0.00119 
  17   rs2289764    C    T      DOM          46/44         49/58        0.553    1       0.4569 
  17   rs2289764    C    T      REC          33/57         15/92        13.60    1     0.000225 
  17   rs4396582    G    A     GENO       23/42/32      29/73/39        1.661    2       0.4357 
  17   rs4396582    G    A    TREND          88/106       131/151         0.055    1       0.8141 
  17   rs4396582    G    A  ALLELIC          88/106       131/151         0.055    1       0.8141 
  17   rs4396582    G    A      DOM           65/32        102/39          0.78    1       0.3771 
  17   rs4396582    G    A      REC           23/74        29/112         0.333    1       0.5640 
   7   rs2374261    T    C     GENO        11/29/24      26/44/34        1.963    2        0.375 
   7   rs2374261    T    C    TREND            51/77        96/112        1.282    1       0.2575 
   7   rs2374261    T    C  ALLELIC            51/77        96/112        2.085    1        0.148 
   7   rs2374261    T    C      DOM           40/24         70/34        0.405    1       0.5244 
   7   rs2374261    T    C      REC            11/53         26/78        1.408    1       0.2353 
Osteoporosis 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected        X2.        DF     P-value 
   1   rs1010447    T    C     GENO          1/6/3     74/228/228        1.153    2       0.5618 
   1   rs1010447    T    C    TREND           8/12        376/684       0.1666    1       0.6832 
   1   rs1010447    T    C  ALLELIC           8/12        376/684       0.1757    1       0.6751 
   1   rs1010447    T    C      DOM            7/3        302/228         0.68    1       0.4097 
   1   rs1010447    T    C      REC            1/9         74/456         0.129    1       0.7196 
   1  rs11580061    G    A     GENO         3/1/14       0/25/428       55.482   2     0.000047 
   1  rs11580061    G    A    TREND          7/29         25/881        25.34   1   4.794e-007 
   1  rs11580061    G    A  ALLELIC          7/29         25/881        29.37   1   5.971e-008 
   1  rs11580061    G    A      DOM           4/14         25/428         8.36    1      0.00384 
   1  rs11580061    G    A      REC           3/15          0/453        75.98    1     0.000032 
   1  rs11121718    C    T     GENO         0/2/15       3/30/465        1.021    2       0.6002 
   1  rs11121718    C    T    TREND           2/32         36/960       0.4228    1       0.5155 
   1  rs11121718    C    T  ALLELIC           2/32         36/960       0.4759    1       0.4903 
   1  rs11121718    C    T      DOM           2/15         33/465        0.685    1       0.4078 
   1  rs11121718    C    T      REC           0/17          3/495        0.103    1       0.7482 
   5   rs2043112    A    G     GENO          2/7/8     80/195/215        0.257    2       0.8793 
   5   rs2043112    A    G    TREND          11/23        355/625       0.1879    1       0.6647 
   5   rs2043112    A    G  ALLELIC          11/23        355/625       0.2135    1        0.644 
   5   rs2043112    A    G      DOM            9/8        275/215        0.067    1       0.7950 
   5   rs2043112    A    G      REC           2/15         80/410        0.252    1       0.6155 
   5   rs1239265    A    T     GENO         2/0/12       2/10/183       12.811    2     0.001653 
   5   rs1239265    A    T    TREND           4/24         14/376         5.11    1      0.02379 
   5   rs1239265    A    T  ALLELIC           4/24         14/376        7.253    1     0.007079 
   5   rs1239265    A    T      DOM           2/12         12/183        1.382    1      0.23975 
   5   rs1239265    A    T      REC           2/12          2/193        12.23    1      0.00047 
   5  rs13166875    G    A     GENO          2/7/7     54/159/193        0.136    2       0.9340 
   5  rs13166875    G    A    TREND          11/21        267/545      0.02801    1       0.8671 
   5  rs13166875    G    A  ALLELIC          11/21        267/545      0.03108    1       0.8601 
   5  rs13166875    G    A      DOM            9/7        213/193        0.089    1       0.7660 
   5  rs13166875    G    A      REC           2/14         54/352        0.009    1       0.0743 
   5   rs1423688    G    T     GENO          3/9/3     80/164/179        3.398    2       0.1828 
   5   rs1423688    G    T    TREND          15/15        324/522        1.432    1       0.2314 
   5   rs1423688    G    T  ALLELIC          15/15        324/522        1.672    1       0.1959 
   5   rs1423688    G    T      DOM           12/3        244/179        2.971    1       0.0847 
   5   rs1423688    G    T      REC           3/12         80/343        0.011    1       0.9158 
   7   rs1109089    T    C     GENO         0/12/7     98/231/167        4.875    2       0.0873 
   7   rs1109089    T    C    TREND          12/26        427/565          1.9    1       0.1681 
   7   rs1109089    T    C  ALLELIC          12/26        427/565        1.967    1       0.1607 
   7   rs1109089    T    C      DOM           12/7        329/167        0.082    1       0.7741 
   7   rs1109089    T    C      REC           0/19         98/398        4.636    1       0.0313 
   7   rs3753151    C    T     GENO         4/10/4     86/182/126        0.844    2       0.6566 
   7   rs3753151    C    T    TREND          18/18        354/434       0.3382    1       0.5609 
   7   rs3753151    C    T  ALLELIC          18/18        354/434       0.3582    1       0.5495 
   7   rs3753151    C    T      DOM           14/4        268/126        0.759    1       0.3836 
   7   rs3753151    C    T      REC           4/14         86/308        0.002    1       0.9657 
   7   rs2299967    T    C     GENO         2/12/4    118/249/138        2.354    2       0.3081 
 lxxviii 
   7   rs2299967    T    C    TREND          16/20        485/525        0.178    1       0.6731 
   7   rs2299967    T    C  ALLELIC          16/20        485/525       0.1781    1        0.673 
   7   rs2299967    T    C      DOM           14/4        367/138        0.229    1       0.6323 
   7   rs2299967    T    C      REC           2/16        118/387        1.476    1       0.2243 
   7   rs2374261    T    C     GENO          3/5/6     97/201/169        0.339    2       0.8439 
   7   rs2374261    T    C    TREND          11/17        395/539      0.08972    1       0.7645 
   7   rs2374261    T    C  ALLELIC          11/17        395/539       0.1007    1        0.751 
   7   rs2374261    T    C      DOM            8/6        298/169        0.261    1       0.6093 
   7   rs2374261    T    C      REC           3/11         97/370        0.004    1       0.9523 
   9   rs1050700    C    T     GENO          2/7/8     40/214/191        0.367    2       0.8321 
   9   rs1050700    C    T    TREND          11/23        294/596     0.007473    1       0.9311 
   9   rs1050700    C    T  ALLELIC          11/23        294/596     0.006864    1        0.934 
   9   rs1050700    C    T      DOM            9/8        254/191        0.114    1       0.7352 
   9   rs1050700    C    T      REC           2/15         40/405        0.153    1       0.6959 
  16   rs2073636    A    G     GENO          4/5/8     63/232/198         2.74    2        0.254 
  16   rs2073636    A    G    TREND          13/21        358/628      0.05295    1        0.818 
  16   rs2073636    A    G  ALLELIC          13/21        358/628      0.05273    1       0.8184 
  16   rs2073636    A    G      DOM            9/8        295/198        0.325    1       0.5688 
  16   rs2073636    A    G      REC           4/13         63/430        1.593    1       0.2069 
  16   rs7187438    C    T     GENO          5/8/4    100/237/159        1.065    2       0.5871 
  16   rs7187438    C    T    TREND          18/16        437/555        1.019    1       0.3127 
  16   rs7187438    C    T  ALLELIC          18/16        437/555        1.052    1        0.305 
  16   rs7187438    C    T      DOM           13/4        337/159        0.551    1       0.4577 
  16   rs7187438    C    T      REC           5/12        100/396        0.864    1       0.3526 
  16   rs1051771    C    G     GENO        2/2/13       3/60/416      20.417    2       4.0e-5 
  16   rs1051771    C    G    TREND           6/28         66/892        5.268    1      0.02172 
  16   rs1051771    C    G  ALLELIC           6/28         66/892        5.645    1       0.0175 
  16   rs1051771    C    G      DOM           4/13         63/416       1.513    1       0.2186 
  16   rs1051771    C    G      REC          2/15          3/476       20.41    1       1.0e-5 
  17    rs196929    T    C     GENO          4/7/7     63/193/210        1.122    2       0.5705 
  17    rs196929    T    C    TREND          15/21        319/613       0.7818    1       0.3766 
  17    rs196929    T    C  ALLELIC          15/21        319/613       0.8488    1       0.3569 
  17    rs196929    T    C      DOM           11/7        256/210        0.267    1       0.6052 
  17    rs196929    T    C      REC           4/14         63/403        1.101    1       0.2941 
  17  rs16947425    A    C     GENO        5/4/10     12/145/320      31.303    2       5.0e-5 
  17  rs16947425    A    C    TREND          14/24        169/785        8.873    1     0.002895 
  17  rs16947425    A    C  ALLELIC          14/24        169/785        8.887    1     0.002872 
  17  rs16947425    A    C      DOM           9/10        157/320        1.714    1       0.1904 
  17  rs16947425    A    C      REC           5/14         12/465        31.27    1      0.00021 
  17    rs196950    T    C     GENO          5/6/5     98/171/228          1.8    2       0.4066 
  17    rs196950    T    C    TREND          16/16        367/627        1.795    1       0.1803 
  17    rs196950    T    C  ALLELIC          16/16        367/627        2.267    1       0.1322 
  17    rs196950    T    C      DOM           11/5        269/228        1.337    1       0.2475 
  17    rs196950    T    C      REC           5/11         98/399        1.285    1       0.2571 
  17   rs1874087    T    C     GENO          8/7/3    143/207/156        2.746    2       0.2533 
  17   rs1874087    T    C    TREND          23/13        493/519        2.707    1      0.09992 
  17   rs1874087    T    C  ALLELIC          23/13        493/519        3.202    1      0.07354 
  17   rs1874087    T    C      DOM           15/3        350/156         1.65    1        0.199 
  17   rs1874087    T    C      REC           8/10        143/363        2.219    1       0.1362 
  17  rs11655020    A    G     GENO          5/7/5     53/253/199         5.98    2      0.05029 
  17  rs11655020    A    G    TREND          17/17        359/651        3.244    1      0.07166 
  17  rs11655020    A    G  ALLELIC          17/17        359/651        2.983    1      0.08416 
  17  rs11655020    A    G      DOM           12/5        306/199         0.69    1       0.4062 
  17  rs11655020    A    G      REC           5/12         53/452        5.959    1      0.01464 
  17   rs4255830    G    A     GENO         4/10/5    118/243/139        0.126    2       0.9389 
  17   rs4255830    G    A    TREND          18/20        479/521     0.004051    1       0.9493 
  17   rs4255830    G    A  ALLELIC          18/20        479/521     0.004145    1       0.9487 
  17   rs4255830    G    A      DOM           14/5        361/139         0.02    1       0.8872 
  17   rs4255830    G    A      REC           4/15        118/382        0.066    1       0.7971 
  17   rs4396582    G    A     GENO         5/10/4    118/239/133        0.345    2       0.8413 
  17   rs4396582    G    A    TREND          20/18        475/505       0.2485    1       0.6181 
  17   rs4396582    G    A  ALLELIC          20/18        475/505       0.2537    1       0.6145 
  17   rs4396582    G    A      DOM           15/4        357/133        0.345    1       0.5570 
 lxxix 
  17   rs4396582    G    A      REC           5/14        118/372         0.05    1       0.8233 
  17  rs11651724    A    G     GENO         3/1/11     12/103/234        12.284   2      0.00215 
  17  rs11651724    A    G    TREND           7/23        127/571       0.4822    1       0.4874 
  17  rs11651724    A    G  ALLELIC           7/23        127/571       0.5057    1        0.477 
  17  rs11651724    A    G      DOM           4/11        115/234        0.258    1       0.6114 
  17  rs11651724    A    G      REC           3/12         12/337        9.984    1      0.00158 
  17   rs2289764    C    T     GENO          5/3/8     57/165/239        5.528    2      0.06303 
  17   rs2289764    C    T    TREND          13/19        279/643        1.336    1       0.2478 
  17   rs2289764    C    T  ALLELIC          13/19        279/643        1.564    1        0.211 
  17   rs2289764    C    T      DOM            8/8        222/239        0.021    1       0.8846 
  17   rs2289764    C    T      REC           5/11         57/404        4.877    1       0.0272 
  17   rs1012117    A    G     GENO          5/5/5     53/213/215        7.015    2      0.02998 
  17   rs1012117    A    G    TREND          15/15        319/643        3.636    1      0.05654 
  17   rs1012117    A    G  ALLELIC          15/15        319/643        3.694    1       0.0546 
  17   rs1012117    A    G      DOM           10/5        266/215       0.7613    1       0.3829 
  17   rs1012117    A    G      REC           5/10         53/428        7.014    1     0.008085 
  22   rs2097461    C    T     GENO          7/5/4     71/211/228        11.06    2      0.00396 
  22   rs2097461    C    T    TREND          19/13        353/667        7.558    1     0.005975 
  22   rs2097461    C    T  ALLELIC          19/13        353/667        8.327    1     0.003907 
  22   rs2097461    C    T      DOM           12/4        282/228        2.444    1        0.118 
  22   rs2097461    C    T      REC            7/9         71/439        10.93    1      0.00095 
  22   rs2239815    C    T     GENO          7/6/5     90/203/212        5.209    2      0.07394 
  22   rs2239815    C    T    TREND          20/16        383/627        3.947    1      0.04695 
  22   rs2239815    C    T  ALLELIC          20/16        383/627        4.564    1      0.03264 
  22   rs2239815    C    T      DOM           13/5        293/212        1.444    1       0.2295 
  22   rs2239815    C    T      REC           7/11         90/415        5.106    1      0.02384 
Temporomandibular joint symptoms 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected       X2.         DF     P-value 
  17   rs196929    T    C     GENO     67/174/256     81/231/328        0.242    2        0.886 
  17   rs196929    T    C    TREND        308/686        393/887      0.01801    1       0.8932 
  17   rs196929    T    C  ALLELIC        308/686        393/887      0.02098    1       0.8848 
  17   rs196929    T    C      DOM        241/256        312/328     0.007515    1       0.9309 
  17   rs196929    T    C      REC         67/430         81/559        0.168    1       0.6819 
  17   rs196950    T    C     GENO     95/170/218    114/197/309        2.449    2        0.294 
  17   rs196950    T    C    TREND        360/606        425/815        1.665    1       0.1969 
  17   rs196950    T    C  ALLELIC        360/606        425/815        2.122    1       0.1452 
  17   rs196950    T    C      DOM        265/218        311/309        2.408    1       0.1207 
  17   rs196950    T    C      REC         95/388        114/506       0.2904    1         0.59 
  17  rs1874087    T    C     GENO    106/177/180    142/253/222         1.11    2       0.5742 
  17  rs1874087    T    C    TREND        389/537        537/697        0.414    1         0.52 
  17  rs1874087    T    C  ALLELIC        389/537        537/697       0.4914    1       0.4833 
  17  rs1874087    T    C      DOM        283/180        395/222       0.9496    1       0.3298 
  17  rs1874087    T    C      REC        106/357        142/475     0.002168    1       0.9629 
  17  rs1665020    A    G     GENO     40/105/294     53/167/328        5.842    2      0.05388 
  17  rs1665020    A    G    TREND        185/693        273/823        3.285    1       0.0699 
  17  rs1665020    A    G  ALLELIC        185/693        273/823         4.03    1      0.04469 
  17  rs1665020    A    G      DOM        145/294        220/328        5.297    1      0.02137 
  17  rs1665020    A    G      REC         40/399         53/495      0.08953    1       0.7648 
  22  rs2097461    C    T     GENO     69/213/182     81/266/273        2.629    2       0.2687 
  22  rs2097461    C    T    TREND        351/577        428/812        2.424    1       0.1195 
  22  rs2097461    C    T  ALLELIC        351/577        428/812        2.522    1       0.1123 
  22  rs2097461    C    T      DOM        282/182        347/273        2.519    1       0.1125 
  22  rs2097461    C    T      REC         69/395         81/539       0.7261    1       0.3941 
  22  rs2239815    C    T     GENO     72/197/183     92/244/265        1.402    2       0.4962 
  22  rs2239815    C    T    TREND        341/563        428/774       0.9069    1       0.3409 
  22  rs2239815    C    T  ALLELIC        341/563        428/774       0.9946    1       0.3186 
  22  rs2239815    C    T      DOM        269/183        336/265        1.373    1       0.2414 
  22  rs2239815    C    T      REC         72/380         92/509      0.07576    1       0.7831 
Dental caries and periodontal disease combined 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected         X2.       DF     P-value 
  12   rs1012117    A    G     GENO     17/115/120     47/176/187        3.989    2       0.1361 
  12   rs1012117    A    G    TREND        149/355        270/550        1.659    1       0.1977 
 lxxx 
  12   rs1012117    A    G  ALLELIC        149/355        270/550        1.632    1       0.2014 
  12   rs1012117    A    G      DOM        132/120        223/187       0.2534    1       0.6147 
  12   rs1012117    A    G      REC         17/235         47/363        3.977    1      0.04612 
  12   rs1010447    T    C     GENO     41/137/137     57/204/186       0.3544    2       0.8376 
  12   rs1010447    T    C    TREND        219/411        318/576       0.1039    1       0.7473 
  12   rs1010447    T    C  ALLELIC        219/411        318/576       0.1059    1       0.7449 
  12   rs1010447    T    C      DOM        178/137        261/186       0.2678    1       0.6048 
  12   rs1010447    T    C      REC         41/274         57/390      0.01151    1       0.9146 
  12   rs1050700    C    T     GENO     27/109/117     35/169/174       0.4003    2       0.8186 
  12   rs1050700    C    T    TREND        163/343        239/517      0.05097    1       0.8214 
  12   rs1050700    C    T  ALLELIC        163/343        239/517      0.05022    1       0.8227 
  12   rs1050700    C    T      DOM        136/117        204/174     0.002775    1        0.958 
  12   rs1050700    C    T      REC         27/226         35/343       0.3414    1        0.559 
  12   rs1051771    C    G     GENO       0/36/247       2/51/359         1.39    2       0.4991 
  12   rs1051771    C    G    TREND         36/530         55/769      0.05546    1       0.8138 
  12   rs1051771    C    G  ALLELIC         36/530         55/769      0.05419    1       0.8159 
  12   rs1051771    C    G      DOM         36/247         53/359         0.003    1       0.9557 
  12   rs1051771    C    G      REC          0/283          2/410         1.378    1       0.2404 
  12   rs1109089    T    C     GENO     58/119/114     99/192/129        5.545    2      0.06249 
  12   rs1109089    T    C    TREND        235/347        390/450        4.594    1      0.03209 
  12   rs1109089    T    C  ALLELIC        235/347        390/450        5.109    1       0.0238 
  12   rs1109089    T    C      DOM        177/114        291/129         5.47    1      0.01934 
  12   rs1109089    T    C      REC         58/233         99/321        1.324    1       0.2499 
  12  rs11655020    A    G     GENO     24/142/130     40/228/159        3.271    2       0.1949 
  12  rs11655020    A    G    TREND        190/402        308/546        2.817    1      0.09326 
  12  rs11655020    A    G  ALLELIC        190/402        308/546        2.442    1       0.1181 
  12  rs11655020    A    G      DOM        166/130        268/159        3.253    1      0.07128 
  12  rs11655020    A    G      REC         24/272         40/387       0.3437    1       0.5577 
  12  rs11651724    A    G     GENO       10/53/86      13/95/158       0.6199    2       0.7335 
  12  rs11651724    A    G    TREND         73/225        121/411        0.326    1        0.568 
  12  rs11651724    A    G  ALLELIC         73/225        121/411       0.3275    1       0.5672 
  12  rs11651724    A    G      DOM          63/86        108/158       0.1113    1       0.7387 
  12  rs11651724    A    G      REC         10/139         13/253       0.6071    1       0.4359 
  12   rs1239265    A    T     GENO       3/13/160       2/15/185        0.368    2       0.8320 
  12   rs1239265    A    T    TREND         19/333         19/385       0.1554    1       0.6935 
  12   rs1239265    A    T  ALLELIC         19/333         19/385       0.1902    1       0.6628 
  12   rs1239265    A    T      DOM         16/160         17/185        0.054    1       0.8165 
  12   rs1239265    A    T      REC          3/173          2/200        0.368    1       0.5442 
  12  rs13166875    G    A     GENO       33/99/85     43/139/142        1.237    2       0.5388 
  12  rs13166875    G    A    TREND        165/269        225/423        1.171    1       0.2791 
  12  rs13166875    G    A  ALLELIC        165/269        225/423        1.225    1       0.2684 
  12  rs13166875    G    A      DOM         132/85        182/142        1.157    1       0.2821 
  12  rs13166875    G    A      REC         33/184         43/281       0.4033    1       0.5254 
  12   rs1423688    G    T     GENO     30/114/100     67/151/140         4.52    2       0.1043 
  12   rs1423688    G    T    TREND        174/314        285/431        1.985    1       0.1589 
  12   rs1423688    G    T  ALLELIC        174/314        285/431        2.117    1       0.1456 
  12   rs1423688    G    T      DOM        144/100        218/140       0.2133    1       0.6442 
  12   rs1423688    G    T      REC         30/214         67/291        4.425    1      0.03542 
  12  rs16947425    A    C     GENO       6/84/187      8/107/294        1.515    2        0.469 
  12  rs16947425    A    C    TREND         96/458        123/695        1.344    1       0.2463 
  12  rs16947425    A    C  ALLELIC         96/458        123/695        1.293    1       0.2554 
  12  rs16947425    A    C      DOM         90/187        115/294        1.508    1       0.2195 
  12  rs16947425    A    C      REC          6/271          8/401      0.03646    1       0.8486 
  12   rs1874087    T    C     GENO      80/118/88    111/177/131       0.1903    2       0.9092 
  12   rs1874087    T    C    TREND        278/294        399/439       0.1144    1       0.7351 
  12   rs1874087    T    C  ALLELIC        278/294        399/439        0.133    1       0.7154 
  12   rs1874087    T    C      DOM         198/88        288/131       0.0195    1       0.8889 
  12   rs1874087    T    C      REC         80/206        111/308       0.1886    1       0.6641 
  12    rs196950    T    C     GENO     63/104/122     76/142/205        3.042    2       0.2185 
  12    rs196950    T    C    TREND        230/348        294/552        2.984    1      0.08409 
  12    rs196950    T    C  ALLELIC        230/348        294/552        3.751    1      0.05276 
  12    rs196950    T    C      DOM        167/122        218/205          2.7    1       0.1004 
  12    rs196950    T    C      REC         63/226         76/347        1.605    1       0.2052 
 lxxxi 
  12    rs196929    T    C     GENO      35/98/122     51/145/186      0.04762    2       0.9765 
  12    rs196929    T    C    TREND        168/342        247/517      0.04599    1       0.8302 
  12    rs196929    T    C  ALLELIC        168/342        247/517      0.05204    1       0.8195 
  12    rs196929    T    C      DOM        133/122        196/186      0.04403    1       0.8338 
  12    rs196929    T    C      REC         35/220         51/331      0.01839    1       0.8921 
  12   rs2043112    A    G     GENO     39/126/114     52/171/176       0.7139    2       0.6998 
  12   rs2043112    A    G    TREND        204/354        275/523       0.6076    1       0.4357 
  12   rs2043112    A    G  ALLELIC        204/354        275/523       0.6327    1       0.4264 
  12   rs2043112    A    G      DOM        165/114        223/176       0.7085    1       0.3999 
  12   rs2043112    A    G      REC         39/240         52/347       0.1264    1       0.7222 
  12   rs2073636    A    G     GENO     28/127/123     53/166/184        2.156    2       0.3403 
  12   rs2073636    A    G    TREND        183/373        272/534       0.0994    1       0.7525 
  12   rs2073636    A    G  ALLELIC        183/373        272/534       0.1027    1       0.7486 
  12   rs2073636    A    G      DOM        155/123        219/184       0.1327    1       0.7157 
  12   rs2073636    A    G      REC         28/250         53/350        1.489    1       0.2224 
  12   rs2097461    C    T     GENO     49/115/129     68/176/184        0.269    2       0.8742 
  12   rs2097461    C    T    TREND        213/373        312/544     0.001344    1       0.9708 
  12   rs2097461    C    T  ALLELIC        213/373        312/544     0.001517    1       0.9689 
  12   rs2097461    C    T      DOM        164/129        244/184      0.07609    1       0.7827 
  12   rs2097461    C    T      REC         49/244         68/360      0.08936    1        0.765 
  12   rs2239815    C    T     GENO     53/113/120     76/172/173       0.1286    2       0.9377 
  12   rs2239815    C    T    TREND        219/353        324/518     0.004677    1       0.9455 
  12   rs2239815    C    T  ALLELIC        219/353        324/518     0.005369    1       0.9416 
  12   rs2239815    C    T      DOM        166/120        248/173      0.05256    1       0.8187 
  12   rs2239815    C    T      REC         53/233         76/345      0.02622    1       0.8714 
  12   rs2289764    C    T     GENO     31/102/145     52/139/203       0.6562    2       0.7203 
  12   rs2289764    C    T    TREND        164/392        243/545       0.2414    1       0.6232 
  12   rs2289764    C    T  ALLELIC        164/392        243/545       0.2777    1       0.5982 
  12   rs2289764    C    T      DOM        133/145        191/203      0.02636    1        0.871 
  12   rs2289764    C    T      REC         31/247         52/342       0.6308    1       0.4271 
  12   rs2299967    T    C     GENO      63/137/80    100/201/128       0.2939    2       0.8633 
  12   rs2299967    T    C    TREND        263/297        401/457     0.006766    1       0.9344 
  12   rs2299967    T    C  ALLELIC        263/297        401/457     0.007055    1       0.9331 
  12   rs2299967    T    C      DOM         200/80        301/128       0.1309    1       0.7175 
  12   rs2299967    T    C      REC         63/217        100/329      0.06279    1       0.8021 
  12   rs2374261    T    C     GENO     54/110/117     93/179/122        8.239    2      0.01625 
  12   rs2374261    T    C    TREND        218/344        365/423        6.723    1     0.009516 
  12   rs2374261    T    C  ALLELIC        218/344        365/423         7.58    1       0.0059 
  12   rs2374261    T    C      DOM        164/117        272/122        8.169    1     0.004262 
  12   rs2374261    T    C      REC         54/227         93/301        1.853    1       0.1734 
  12   rs3753151    C    T     GENO      47/100/88     63/142/119      0.09141    2       0.9553 
  12   rs3753151    C    T    TREND        194/276        268/380    0.0006728    1       0.9793 
  12   rs3753151    C    T  ALLELIC        194/276        268/380    0.0007449    1       0.9782 
  12   rs3753151    C    T      DOM         147/88        205/119      0.03015    1       0.8622 
  12   rs3753151    C    T      REC         47/188         63/261       0.0266    1       0.8704 
  12   rs4255830    A    G     GENO      82/131/74    105/196/114       0.9526    2       0.6211 
  12   rs4255830    A    G    TREND        295/279        406/424       0.7802    1       0.3771 
  12   rs4255830    A    G  ALLELIC        295/279        406/424       0.8335    1       0.3613 
  12   rs4255830    A    G      DOM         213/74        301/114       0.2459    1         0.62 
  12   rs4255830    A    G      REC         82/205        105/310       0.9285    1       0.3353 
  12   rs4396582    G    A     GENO      75/142/73    114/169/139        6.697    2      0.03514 
  12   rs4396582    G    A    TREND        292/288        397/447        1.337    1       0.2475 
  12   rs4396582    G    A  ALLELIC        292/288        397/447        1.505    1       0.2199 
  12   rs4396582    G    A      DOM         217/73        283/139        4.958    1      0.02598 
  12   rs4396582    G    A      REC         75/215        114/308        0.117    1       0.7323 
  12   rs7187438    C    T     GENO      56/141/96     73/205/147       0.5328    2       0.7661 
  12   rs7187438    C    T    TREND        253/333        351/499       0.4974    1       0.4806 
  12   rs7187438    C    T  ALLELIC        253/333        351/499        0.503    1       0.4782 
  12   rs7187438    C    T      DOM         197/96        278/147       0.2576    1       0.6118 
  12   rs7187438    C    T      REC         56/237         73/352       0.4411    1       0.5066 
Dental caries and periapical lesions combined 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected         X2      DF     P-value 
 lxxxii 
   1   rs1010447    T    C     GENO       14/46/56     36/127/129       0.6004    2       0.7407 
   1   rs1010447    T    C    TREND         74/158        199/385       0.3379    1        0.561 
   1   rs1010447    T    C  ALLELIC         74/158        199/385        0.354    1       0.5518 
   1   rs1010447    T    C      DOM          60/56        163/129       0.5625    1       0.4533 
   1   rs1010447    T    C      REC         14/102         36/256     0.005211    1       0.9425 
   4   rs2043112    A    G     GENO       16/40/49     42/118/111        1.117    2       0.5721 
   4   rs2043112    A    G    TREND         72/138        202/340       0.5324    1       0.4656 
   4   rs2043112    A    G  ALLELIC         72/138        202/340       0.5818    1       0.4456 
   4   rs2043112    A    G      DOM          56/49        160/111        1.008    1       0.3153 
   4   rs2043112    A    G      REC          16/89         42/229     0.003923    1       0.9501 
   5   rs1239265    A    T     GENO         2/7/56       2/10/105        0.637    2       0.7271 
   5   rs1239265    A    T    TREND         11/119         14/220       0.6321    1       0.4266 
   5   rs1239265    A    T  ALLELIC         11/119         14/220       0.8027    1       0.3703 
   5   rs1239265    A    T      DOM           9/56         12/105       0.528    1       0.4676 
   5   rs1239265    A    T      REC           2/63          2/115        0.364    1       0.5465 
   5  rs13166875    G    A     GENO       11/26/31       30/97/94       0.7511    2       0.6869 
   5  rs13166875    G    A    TREND          48/88        157/285     0.002173    1       0.9628 
   5  rs13166875    G    A  ALLELIC          48/88        157/285     0.002326    1       0.9615 
   5  rs13166875    G    A      DOM          37/31         127/94       0.1976    1       0.6566 
   5  rs13166875    G    A      REC          11/57         30/191       0.2891    1       0.5908 
   5   rs1423688    G    T     GENO       11/34/37      46/86/102          1.7    2       0.4275 
   5   rs1423688    G    T    TREND         56/108        178/290        0.664    1       0.4152 
   5   rs1423688    G    T  ALLELIC         56/108        178/290       0.7873    1       0.3749 
   5   rs1423688    G    T      DOM          45/37        132/102      0.05786    1       0.8099 
   5   rs1423688    G    T      REC          11/71         46/188        1.601    1       0.2058 
   7   rs1109089    T    C     GENO       12/46/51      57/146/82        12.54    2     0.001893 
   7   rs1109089    T    C    TREND         70/148        260/310        11.83    1     0.000584 
   7   rs1109089    T    C  ALLELIC         70/148        260/310        11.81    1    0.0005878 
   7   rs1109089    T    C      DOM          58/51         203/82        11.45    1    0.0007166 
   7   rs1109089    T    C      REC          12/97         57/228        4.412    1      0.03569 
   7   rs3753151    C    T     GENO       26/39/30      39/116/73        4.863    2      0.08791 
   7   rs3753151    C    T    TREND          91/99        194/262        1.517    1       0.2181 
   7   rs3753151    C    T  ALLELIC          91/99        194/262        1.558    1        0.212 
   7   rs3753151    C    T      DOM          65/30         155/73     0.005939    1       0.9386 
   7   rs3753151    C    T      REC          26/69         39/189        4.394    1      0.03606 
   7   rs2299967    T    C     GENO       28/53/25      67/143/79       0.7554    2       0.6854 
   7   rs2299967    T    C    TREND        109/103        277/301       0.7513    1       0.3861 
   7   rs2299967    T    C  ALLELIC        109/103        277/301       0.7566    1       0.3844 
   7   rs2299967    T    C      DOM          81/25         210/79       0.5625    1       0.4533 
   7   rs2299967    T    C      REC          28/78         67/222       0.4434    1       0.5055 
   7   rs2374261    T    C     GENO       12/44/49      57/133/78        11.73    2     0.002836 
   7   rs2374261    T    C    TREND         68/142        247/289         11.3    1    0.0007748 
   7   rs2374261    T    C  ALLELIC         68/142        247/289        11.61    1    0.0006558 
   7   rs2374261    T    C      DOM          56/49         190/78        10.36    1     0.001286 
   7   rs2374261    T    C      REC          12/93         57/211        4.845    1      0.02772 
   9   rs1050700    C    T     GENO        2/41/49     27/115/119        6.372    2      0.04133 
   9   rs1050700    C    T    TREND         45/139        169/353        4.234    1      0.03963 
   9   rs1050700    C    T  ALLELIC         45/139        169/353        4.039    1      0.04447 
   9   rs1050700    C    T      DOM          43/49        142/119        1.603    1       0.2054 
   9   rs1050700    C    T      REC           2/90         27/234        6.023    1       0.0141 
  16   rs2073636    A    G     GENO       12/54/43     37/107/128        3.328    2       0.1894 
  16   rs2073636    A    G    TREND         78/140        181/363       0.4122    1       0.5209 
  16   rs2073636    A    G  ALLELIC         78/140        181/363       0.4362    1       0.5089 
  16   rs2073636    A    G      DOM          66/43        144/128        1.821    1       0.1772 
  16   rs2073636    A    G      REC          12/97         37/235       0.4671    1       0.4943 
  16   rs7187438    C    T     GENO       25/50/34     48/139/100        2.073    2       0.3547 
  16   rs7187438    C    T    TREND        100/118        235/339         1.54    1       0.2147 
  16   rs7187438    C    T  ALLELIC        100/118        235/339        1.574    1       0.2096 
  16   rs7187438    C    T      DOM          75/34        187/100       0.4702    1       0.4929 
  16   rs7187438    C    T      REC          25/84         48/239        2.027    1       0.1545 
  16   rs1051771    C    G     GENO        0/11/95       2/37/239        1.408    2       0.4946 
  16   rs1051771    C    G    TREND         11/201         41/515         1.15    1       0.2836 
  16   rs1051771    C    G  ALLELIC         11/201         41/515        1.161    1       0.2812 
 lxxxiii 
  16   rs1051771    C    G      DOM          11/95         39/239        0.903    1       0.3418 
  16   rs1051771    C    G      REC          0/106          2/276        1.319    1       0.2508 
  17    rs196929    T    C     GENO       16/38/48      25/97/138          2.9    2       0.2345 
  17    rs196929    T    C    TREND         70/134        147/373        2.294    1       0.1298 
  17    rs196929    T    C  ALLELIC         70/134        147/373         2.55    1       0.1103 
  17    rs196929    T    C      DOM          54/48        122/138        1.062    1       0.3027 
  17    rs196929    T    C      REC          16/86         25/235        2.688    1       0.1011 
  17  rs16947425    A    C     GENO        6/28/71       5/75/193         4.05    2        0.132 
  17  rs16947425    A    C    TREND         40/170         85/461        1.314    1       0.2517 
  17  rs16947425    A    C  ALLELIC         40/170         85/461        1.331    1       0.2487 
  17  rs16947425    A    C      DOM          34/71         80/193       0.3409    1       0.5593 
  17  rs16947425    A    C      REC           6/99          5/268        4.046    1      0.04427 
  17    rs196950    T    C     GENO       22/42/46      39/96/143         3.58    2       0.1669 
  17    rs196950    T    C    TREND         86/134        174/382        3.578    1      0.05855 
  17    rs196950    T    C  ALLELIC         86/134        174/382          4.3    1      0.03811 
  17    rs196950    T    C      DOM          64/46        135/143         2.92    1      0.08749 
  17    rs196950    T    C      REC          22/88         39/239        2.121    1       0.1453 
  17   rs1874087    T    C     GENO       33/42/36      60/122/91        2.845    2       0.2412 
  17   rs1874087    T    C    TREND        108/114        242/304        1.046    1       0.3065 
  17   rs1874087    T    C  ALLELIC        108/114        242/304        1.191    1       0.2751 
  17   rs1874087    T    C      DOM          75/36         182/91      0.02894    1       0.8649 
  17   rs1874087    T    C      REC          33/78         60/213        2.584    1        0.108 
  17  rs11655020    A    G     GENO        9/73/29      28/177/83       0.6694    2       0.7156 
  17  rs11655020    A    G    TREND         91/131        233/343       0.0276    1       0.8681 
  17  rs11655020    A    G  ALLELIC         91/131        233/343      0.01935    1       0.8894 
  17  rs11655020    A    G      DOM          82/29         205/83       0.2878    1       0.5916 
  17  rs11655020    A    G      REC          9/102         28/260       0.2481    1       0.6184 
  17   rs4255830    G    A     GENO       21/53/31      64/143/80       0.2678    2       0.8747 
  17   rs4255830    G    A    TREND         95/115        271/303       0.2419    1       0.6228 
  17   rs4255830    G    A  ALLELIC         95/115        271/303       0.2408    1       0.6236 
  17   rs4255830    G    A      DOM          74/31         207/80        0.103    1       0.7482 
  17   rs4255830    G    A      REC          21/84         64/223       0.2394    1       0.6246 
  17   rs4396582    A    G     GENO       26/51/32      75/133/70       0.8298    2       0.6604 
  17   rs4396582    A    G    TREND        103/115        283/273       0.7962    1       0.3722 
  17   rs4396582    A    G  ALLELIC        103/115        283/273       0.8352    1       0.3608 
  17   rs4396582    A    G      DOM          77/32         208/70       0.7041    1       0.4014 
  17   rs4396582    A    G      REC          26/83         75/203       0.3965    1       0.5289 
  17  rs11651724    A    G     GENO        1/14/37      11/60/111        2.467    2       0.2912 
  17  rs11651724    A    G    TREND          16/88         82/282        2.386    1       0.1224 
  17  rs11651724    A    G  ALLELIC          16/88         82/282        2.493    1       0.1144 
  17  rs11651724    A    G      DOM          15/37         71/111        1.798    1       0.1799 
  17  rs11651724    A    G      REC           1/51         11/171        1.412    1       0.2347 
  17   rs2289764    C    T     GENO       15/29/60      24/97/140         3.98    2       0.1367 
  17   rs2289764    C    T    TREND         59/149        145/377      0.02232    1       0.8812 
  17   rs2289764    C    T  ALLELIC         59/149        145/377       0.0255    1       0.8731 
  17   rs2289764    C    T      DOM          44/60        121/140        0.493    1       0.4826 
  17   rs2289764    C    T      REC          15/89         24/237         2.13    1       0.1445 
  17   rs1012117    A    G     GENO       10/44/45     25/128/122       0.1686    2       0.9191 
  17   rs1012117    A    G    TREND         64/134        178/372    0.0001144    1       0.9915 
  17   rs1012117    A    G  ALLELIC         64/134        178/372    0.0001086    1       0.9917 
  17   rs1012117    A    G      DOM          54/45        153/122      0.03505    1       0.8515 
  17   rs1012117    A    G      REC          10/89         25/250      0.08756    1       0.7673 
  22   rs2097461    C    T     GENO       16/53/42     44/114/138        3.097    2       0.2126 
  22   rs2097461    C    T    TREND         85/137        202/390        1.115    1        0.291 
  22   rs2097461    C    T  ALLELIC         85/137        202/390        1.228    1       0.2678 
  22   rs2097461    C    T      DOM          69/42        158/138        2.525    1        0.112 
  22   rs2097461    C    T      REC          16/95         44/252      0.01303    1       0.9091 
  22   rs2239815    C    T     GENO       22/52/37     46/109/126        4.337    2       0.1144 
  22   rs2239815    C    T    TREND         96/126        201/361        3.355    1      0.06701 
  22   rs2239815    C    T  ALLELIC         96/126        201/361        3.782    1      0.05181 
  22   rs2239815    C    T      DOM          74/37        155/126        4.337    1      0.03729 
  22   rs2239815    C    T      REC          22/89         46/235       0.6604    1       0.4164 
 lxxxiv 
Dental caries, periodontal disease and periapical lesions combined 
 Chromosome    SNP        Allele1/2   TEST     Affected      Unaffected       X2          DF     P-value 
   1   rs1010447    T    C     GENO       11/28/37       23/77/83       0.6399    2       0.7262 
   1   rs1010447    T    C    TREND         50/102        123/243      0.02247    1       0.8808 
   1   rs1010447    T    C  ALLELIC         50/102        123/243      0.02446    1       0.8757 
   1   rs1010447    T    C      DOM          39/37         100/83       0.2393    1       0.6247 
   1   rs1010447    T    C      REC          11/65         23/160       0.1709    1       0.6793 
   4   rs2043112    A    G     GENO        7/25/37       23/69/74        1.717    2       0.4239 
   4   rs2043112    A    G    TREND          39/99        115/217        1.648    1       0.1992 
   4   rs2043112    A    G  ALLELIC          39/99        115/217          1.8    1       0.1797 
   4   rs2043112    A    G      DOM          32/37          92/74          1.6    1       0.2059 
   4   rs2043112    A    G      REC           7/62         23/143       0.6026    1       0.4376 
   5   rs1239265    A    T     GENO         2/5/37        2/10/83       0.697    2       0.7120 
   5   rs1239265    A    T    TREND           9/79         14/176       0.5025    1       0.4784 
   5   rs1239265    A    T  ALLELIC           9/79         14/176       0.6477    1       0.4209 
   5   rs1239265    A    T      DOM           7/37          12/83        0.274    1       0.3951 
   5   rs1239265    A    T      REC           2/42           2/93        0.641    1       0.4397 
   5  rs13166875    G    A     GENO        5/16/21       19/57/59       0.5244    2       0.7693 
   5  rs13166875    G    A    TREND          26/58         95/175        0.471    1       0.4925 
   5  rs13166875    G    A  ALLELIC          26/58         95/175       0.5102    1        0.475 
   5  rs13166875    G    A      DOM          21/21          76/59       0.5127    1        0.474 
   5  rs13166875    G    A      REC           5/37         19/116       0.1286    1       0.7199 
   5   rs1423688    G    T     GENO       10/21/22       33/58/57       0.3055    2       0.8583 
   5   rs1423688    G    T    TREND          41/65        124/172       0.2802    1       0.5965 
   5   rs1423688    G    T  ALLELIC          41/65        124/172       0.3329    1        0.564 
   5   rs1423688    G    T      DOM          31/22          91/57       0.1468    1       0.7016 
   5   rs1423688    G    T      REC          10/43         33/115       0.2729    1       0.6014 
   7   rs1109089    T    C     GENO       10/25/35       38/89/50        10.53    2     0.005156 
   7   rs1109089    T    C    TREND          45/95        165/189        8.138    1     0.004334 
   7   rs1109089    T    C  ALLELIC          45/95        165/189        8.592    1     0.003376 
   7   rs1109089    T    C      DOM          35/35         127/50        10.51    1     0.001184 
   7   rs1109089    T    C      REC          10/60         38/139        1.653    1       0.1985 
   7   rs3753151    C    T     GENO       17/24/21       24/71/47        3.565    2       0.1683 
   7   rs3753151    C    T    TREND          58/66        119/165       0.7931    1       0.3732 
   7   rs3753151    C    T  ALLELIC          58/66        119/165       0.8344    1        0.361 
   7   rs3753151    C    T      DOM          41/21          95/47      0.01159    1       0.9143 
   7   rs3753151    C    T      REC          17/45         24/118        2.973    1      0.08466 
   7   rs2299967    T    C     GENO       20/31/17       46/82/53       0.6212    2        0.733 
   7   rs2299967    T    C    TREND          71/65        174/188       0.6206    1       0.4308 
   7   rs2299967    T    C  ALLELIC          71/65        174/188       0.6778    1       0.4103 
   7   rs2299967    T    C      DOM          51/17         128/53       0.4484    1       0.5031 
   7   rs2299967    T    C      REC          20/48         46/135       0.4055    1       0.5243 
   7   rs2374261    T    C     GENO        8/25/36       38/83/45        14.07    2    0.0008793 
   7   rs2374261    T    C    TREND          41/97        159/173        12.44    1    0.0004212 
   7   rs2374261    T    C  ALLELIC          41/97        159/173        13.18    1    0.0002827 
   7   rs2374261    T    C      DOM          33/36         121/45        13.56    1    0.0002314 
   7   rs2374261    T    C      REC           8/61         38/128        3.951    1      0.04683 
   9   rs1050700    C    T     GENO        1/26/27       11/75/78        1.841    2       0.3982 
   9   rs1050700    C    T    TREND          28/80         97/231       0.6094    1        0.435 
   9   rs1050700    C    T  ALLELIC          28/80         97/231       0.5285    1       0.4672 
   9   rs1050700    C    T      DOM          27/27          86/78        0.097    1       0.7557 
   9   rs1050700    C    T      REC           1/53         11/153        1.841    1       0.1748 
  16   rs2073636    A    G     GENO        7/33/31       22/61/85        2.237    2       0.3267 
  16   rs2073636    A    G    TREND          47/95        105/231       0.1439    1       0.7045 
  16   rs2073636    A    G  ALLELIC          47/95        105/231       0.1573    1       0.6917 
  16   rs2073636    A    G      DOM          40/31          83/85       0.9605    1       0.3271 
  16   rs2073636    A    G      REC           7/64         22/146       0.4902    1       0.4838 
  16   rs7187438    C    T     GENO       17/33/19       31/78/70        3.437    2       0.1793 
  16   rs7187438    C    T    TREND          67/71        140/218        3.384    1      0.06583 
  16   rs7187438    C    T  ALLELIC          67/71        140/218        3.654    1      0.05594 
  16   rs7187438    C    T      DOM          50/19         109/70        2.898    1      0.08872 
  16   rs7187438    C    T      REC          17/52         31/148        1.709    1       0.1911 
 lxxxv 
  16   rs1051771    C    G     GENO         0/6/61       1/23/151        1.217    2       0.5441 
  16   rs1051771    C    G    TREND          6/128         25/325        1.148    1        0.284 
  16   rs1051771    C    G  ALLELIC          6/128         25/325        1.148    1       0.2839 
  16   rs1051771    C    G      DOM           6/61         24/151         1.01    1       0.3148 
  16   rs1051771    C    G      REC           0/67          1/174        0.384    1       0.5352 
  17    rs196929    T    C     GENO       10/23/31       17/54/85        1.164    2       0.5587 
  17    rs196929    T    C    TREND          43/85         88/224        1.084    1       0.2978 
  17    rs196929    T    C  ALLELIC          43/85         88/224        1.261    1       0.2616 
  17    rs196929    T    C      DOM          33/31          71/85       0.6663    1       0.4143 
  17    rs196929    T    C      REC          10/54         17/139       0.9421    1       0.3317 
  17  rs16947425    A    C     GENO        4/20/43       3/39/122        4.072    2       0.1305 
  17  rs16947425    A    C    TREND         28/106         45/283         3.54    1       0.0599 
  17  rs16947425    A    C  ALLELIC         28/106         45/283        3.682    1      0.05499 
  17  rs16947425    A    C      DOM          24/43         42/122         2.43    1       0.1190 
  17  rs16947425    A    C      REC           4/63          3/161        2.776    1       0.0957 
  17    rs196950    T    C     GENO       15/27/29       25/56/92        3.387    2       0.1839 
  17    rs196950    T    C    TREND          57/85        106/240         3.31    1      0.06887 
  17    rs196950    T    C  ALLELIC          57/85        106/240        4.089    1      0.04316 
  17    rs196950    T    C      DOM          42/29          81/92        3.064    1      0.08007 
  17    rs196950    T    C      REC          15/56         25/148        1.637    1       0.2008 
  17   rs1874087    T    C     GENO       24/28/20       40/74/54        2.341    2       0.3102 
  17   rs1874087    T    C    TREND          76/68        154/182        1.696    1       0.1928 
  17   rs1874087    T    C  ALLELIC          76/68        154/182        1.948    1       0.1628 
  17   rs1874087    T    C      DOM          52/20         114/54       0.4503    1       0.5022 
  17   rs1874087    T    C      REC          24/48         40/128        2.338    1       0.1263 
  17  rs11655020    A    G     GENO        7/49/17      20/103/58        2.363    2       0.3069 
  17  rs11655020    A    G    TREND          63/83        143/219       0.7568    1       0.3843 
  17  rs11655020    A    G  ALLELIC          63/83        143/219       0.5743    1       0.4486 
  17  rs11655020    A    G      DOM          56/17         123/58        1.917    1       0.1662 
  17  rs11655020    A    G      REC           7/66         20/161       0.1168    1       0.7325 
  17   rs4255830    G    A     GENO       16/32/20       43/86/46       0.2419    2       0.8861 
  17   rs4255830    G    A    TREND          64/72        172/178       0.1657    1        0.684 
  17   rs4255830    G    A  ALLELIC          64/72        172/178       0.1703    1       0.6799 
  17   rs4255830    G    A      DOM          48/20         129/46       0.2419    1       0.6228 
  17   rs4255830    G    A      REC          16/52         43/132      0.02892    1        0.865 
  17   rs4396582    G    A     GENO       19/35/18       48/76/51       0.6386    2       0.7266 
  17   rs4396582    G    A    TREND          73/71        172/178      0.08923    1       0.7652 
  17   rs4396582    G    A  ALLELIC          73/71        172/178      0.09825    1       0.7539 
  17   rs4396582    G    A      DOM          54/18         124/51       0.4349    1       0.5096 
  17   rs4396582    G    A      REC          19/53         48/127      0.02789    1       0.8674 
  17  rs11651724    A    G     GENO         0/5/23       10/42/52        9.848    2      0.00727 
  17  rs11651724    A    G    TREND           5/51         62/146        9.582    1     0.001965 
  17  rs11651724    A    G  ALLELIC           5/51         62/146        10.16    1     0.001438 
  17  rs11651724    A    G      DOM           5/23          52/52         9.29    1       0.0023 
  17  rs11651724    A    G      REC           0/28          10/94        2.913    1       0.0878 
  17   rs2289764    C    T     GENO       10/20/38       18/53/92         0.68    2       0.7118 
  17   rs2289764    C    T    TREND          40/96         89/237       0.1749    1       0.6758 
  17   rs2289764    C    T  ALLELIC          40/96         89/237       0.2125    1       0.6448 
  17   rs2289764    C    T      DOM          30/38          71/92     0.006101    1       0.9377 
  17   rs2289764    C    T      REC          10/58         18/145       0.6044    1       0.4369 
  17   rs1012117    A    G     GENO        5/26/30       17/73/82       0.1573    2       0.9244 
  17   rs1012117    A    G    TREND          36/86        107/237       0.1078    1       0.7427 
  17   rs1012117    A    G  ALLELIC          36/86        107/237       0.1079    1       0.7425 
  17   rs1012117    A    G      DOM          31/30          90/82      0.04091    1       0.8397 
  17   rs1012117    A    G      REC           5/56         17/155       0.1499    1       0.6987 
  22   rs2097461    C    T     GENO        9/32/31       30/81/77       0.4922    2       0.7818 
  22   rs2097461    C    T    TREND          50/94        141/235       0.3246    1       0.5688 
  22   rs2097461    C    T  ALLELIC          50/94        141/235       0.3457    1       0.5565 
  22   rs2097461    C    T      DOM          41/31         111/77      0.09437    1       0.7587 
  22   rs2097461    C    T      REC           9/63         30/158       0.4881    1       0.4848 
  22   rs2239815    C    T     GENO       14/29/27       32/72/70       0.1031    2       0.9497 
  22   rs2239815    C    T    TREND          57/83        136/212      0.09827    1       0.7539 
  22   rs2239815    C    T  ALLELIC          57/83        136/212       0.1115    1       0.7385 
 lxxxvi 
  22   rs2239815    C    T      DOM          43/27         104/70      0.05733    1       0.8108 
  22   rs2239815    C    T      REC          14/56         32/142       0.0845    1       0.7713 
 
Table 13. Dental Registry and DNA Repository (DRDR) codes and their respective Phecodes. 
DRDR Description DRDR Code Phecode PheWAS Description 
Primary Caries DC001 521.1 caries 
Primary Caries - 
1 surface 
DC001A 521.1 caries 
Primary Caries - 
2 surface 
DC001B 521.1 caries 
Primary Caries - 
3 surface 
DC001C 521.1 caries 
Primary Caries - 
4 surface 
DC001D 521.1 caries 
Primary Caries - 
5 surface 
DC001E 521.1 caries 
Secondary Caries DC002 521.1 caries 
Secondary Caries 
- 1 surface 
DC002A 521.1 caries 
Secondary Caries 
- 2 surface 
DC002B 521.1 caries 
Secondary Caries 
- 3 surface 
DC002C 521.1 caries 
Secondary Caries 
- 4 surface 
DC002D 521.1 caries 
Secondary Caries 
- 5 surface 
DC002E 521.1 caries 








DC005 523.32 Chronic periodontitis 
Aggressive 
Periodontitis 









Diseases of pulp and 
periapical tissues 
Impacted tooth DC009 520 
Disorders of tooth 
development 
Bruxism DC010 327.7 
Sleep related movement 
disorders 
Malocclusion DC011 524.3 
Anomalies of tooth 
position/malocclusion 
Abrasion DC012 521 
Dental erosion, abrasion 
and attrition 
Pulpitis DC013 522 
Diseases of pulp and 
periapical tissues 
Agenesis DC015 520.2 
Disturbances in tooth 
eruption 
Prognathism DC016 526.3 
Anomalies of jaw 
size/symmetry 
Retrognathism DC017 526.3 
Anomalies of jaw 
size/symmetry 
 lxxxvii 
TMJ Disorder DC018 526.4 
Temporomandibular joint 
disorders 
Macrodontia DC021 520 
Disorders of tooth 
development 
Microdontia DC022 520 
Disorders of tooth 
development 
Taurodontism DC023 520 










Diseases of hard tissues 
of teeth 
Ameloblastoma DC027 526 Diseases of the jaws 
Mucous retention 
cyst 
DC029 526.1 Cysts of the jaws 
Stomatitis DC030 528.1 Stomatitis and mucositis 
Xerostomia DC031 527.7 




DC032 523.1 Gingivitis 
Missing DC033 525.1 
Loss of teeth or 
edentulism 
Dental fracture DC034 525 Tooth fracture 
Residual tooth 
root 
DC035 525 Tooth fracture 



















Periodontitis (acute or 
chronic) 
Tooth ankylosis DC041 520.2 
Disturbances 
in tooth eruption 
Attrition DC042 521 
Dental erosion, abrasion 
and attrition 




Loss of teeth or 
edentulism 
Total edentulism DC045 525.1 
Loss of teeth or 
edentulism 
Leukoedema DC046 528.6 










Leukoplakia of oral 
mucosa 
Microglossia DC049 529 Diseases of the tongue 
Macroglossia DC050 529 Diseases of the tongue 
Fordyce granules DC051 706 
Diseases of sebaceous 
glands 
Dry/chapped DC052 528.5 Diseases of lips 
Coated DC053 529 Diseases of the tongue 
 lxxxviii 
Pillars/Trigone DC054 695.8 
Other specified 
erythematous conditions 
Fissured DC055 529 Diseases of the tongue 
Ulcers DC057 528.11 
Ulcerative stomatitis & 
mucositis 
Torus maxillary DC058 526.8 Exostosis of jaw 
Torus mandibular DC061 526.8 Exostosis of jaw 
Gingival 
hyperplasia 
DC063 526.3 Gingivitis 
Cyst DC064 526.1 Cysts of the jaws 
Root resorption DC066 521 






Loss of teeth or 
edentulism 
Extracted due to 
caries 
DC069A 525.1 
Loss of teeth or 
edentulism 
Extracted due to 
periodontitis 
DC069B 525.1 
Loss of teeth or 
edentulism 
Ankyloglossia DC071 529 Diseases of the tongue 
Erosion DC074 521 
Diseases of hard tissues 
of teeth 




Disorders of tooth 
development 
Leukoplakia DC080 528.6 
Leukoplakia of oral 
mucosa 
Abfraction DC081 521 
Diseases of hard tissues 
of teeth 
Oral cancer DC087 145 Cancer of mouth 
White line on 
buccal 
DC089 528.6 
Leukoplakia of oral 
mucosa 
Unerupted DC090 520.2 
Disturbances in tooth 
eruption 
Temporary Filling DC091 525 
Other diseases of the 





Congenital anomalies of 
face and neck 
Cleft DC095 749 
Congenital anomalies of 
face and neck 
Cleft, unilateral DC097 749 
Congenital anomalies of 
face and neck 
Cleft, bilateral DC098 749 
Congenital anomalies of 
face and neck 
Lingual 
varicosities 
DC100 454 Varicose veins 
Incipient Caries DC111 521.1 Dental caries 
Lip Chewing DC113 528.5 Diseases of lips 
Tonsils Red DC116 474.2 
Chronic tonsillitis and 
adenoiditis 
Tonsils Swelling DC117 474.2 





Chronic tonsillitis and 
adenoiditis 
 lxxxix 
Tonsils Brodsky DC119 474.2 
Chronic tonsillitis and 
adenoiditis 
Brodsky 2 DC120 474.2 
Chronic tonsillitis and 
adenoiditis 
Rampant Caries DC122 521.1 Dental caries 
Hypodontia DC123 520 
Disorders of tooth 
development 
Calculus DC124 523 
Gingival and periodontal 
diseases 
Partial Eruption DC125 520.2 
Disturbances in tooth 
eruption 
Crowding DC126 524.3 
Anomalies of tooth 
position/malocclusion 
Space DC127 526.3 
Anomalies of jaw 
size/symmetry 
Shifted Mesially DC128 526.3 
Anomalies of jaw 
size/symmetry 
Diastema DC129 526.3 
Anomalies of jaw 
size/symmetry 
Fistula DC133 522 
Diseases of pulp and 
periapical tissues 
Hemangioma DC136 228 
Hemangioma and 
lymphangioma, any site 
Cervical Node DC137 289.4 Lymphadenitis 
Candidiasis DC139 112 Candidiasis 
Tongue Scalloped DC142 529 Diseases of the tongue 
Dry Eyes DC144 375 
Disorders of lacrimal 
system 
Midline shift DC146 524.3 





DC149 529 Diseases of the tongue 
Occlusion 2 DC152 526.3 
Anomalies of jaw 
size/symmetry 
Occlusion 3 DC153 526.3 












Diseases of pulp and 
periapical tissues 
Endodontic 
treatment - molar 
D3330 522 




DC150 529 Diseases of the tongue 
Fibroma DC138 528 
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